<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with OASIS Tables with MathML3 v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archive-oasis-article1-mathml3.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">IUBMB Life</journal-id><journal-id journal-id-type="iso-abbrev">IUBMB Life</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1521-6551</journal-id><journal-id journal-id-type="publisher-id">IUB</journal-id><journal-title-group><journal-title>Iubmb Life</journal-title></journal-title-group><issn pub-type="ppub">1521-6543</issn><issn pub-type="epub">1521-6551</issn><publisher><publisher-name>John Wiley &#x00026; Sons, Inc.</publisher-name><publisher-loc>Hoboken, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7436231</article-id><article-id pub-id-type="doi">10.1002/iub.2356</article-id><article-id pub-id-type="publisher-id">IUB2356</article-id><article-categories><subj-group subj-group-type="overline"><subject>Critical Review</subject></subj-group><subj-group subj-group-type="heading"><subject>Critical Reviews</subject></subj-group></article-categories><title-group><article-title>Bacterial co&#x02010;infections with <styled-content style="fixed-case" toggle="no">SARS&#x02010;CoV</styled-content>&#x02010;2</article-title><alt-title alt-title-type="left-running-head">Mirzaei et al.</alt-title></title-group><contrib-group><contrib id="iub2356-cr-0001" contrib-type="author" corresp="yes"><name><surname>Mirzaei</surname><given-names>Rasoul</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4148-6495</contrib-id><xref ref-type="aff" rid="iub2356-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="iub2356-aff-0002">
<sup>2</sup>
</xref><address><email>rasul.micro92@gmail.com</email></address></contrib><contrib id="iub2356-cr-0002" contrib-type="author"><name><surname>Goodarzi</surname><given-names>Pedram</given-names></name><xref ref-type="aff" rid="iub2356-aff-0003">
<sup>3</sup>
</xref></contrib><contrib id="iub2356-cr-0003" contrib-type="author"><name><surname>Asadi</surname><given-names>Muhammad</given-names></name><xref ref-type="aff" rid="iub2356-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="iub2356-cr-0004" contrib-type="author"><name><surname>Soltani</surname><given-names>Ayda</given-names></name><xref ref-type="aff" rid="iub2356-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="iub2356-cr-0005" contrib-type="author"><name><surname>Aljanabi</surname><given-names>Hussain ali abraham</given-names></name><xref ref-type="aff" rid="iub2356-aff-0004">
<sup>4</sup>
</xref><xref ref-type="aff" rid="iub2356-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="iub2356-cr-0006" contrib-type="author"><name><surname>Jeda</surname><given-names>Ali Salimi</given-names></name><xref ref-type="aff" rid="iub2356-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="iub2356-cr-0007" contrib-type="author"><name><surname>Dashtbin</surname><given-names>Shirin</given-names></name><xref ref-type="aff" rid="iub2356-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="iub2356-cr-0008" contrib-type="author"><name><surname>Jalalifar</surname><given-names>Saba</given-names></name><xref ref-type="aff" rid="iub2356-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="iub2356-cr-0009" contrib-type="author"><name><surname>Mohammadzadeh</surname><given-names>Rokhsareh</given-names></name><xref ref-type="aff" rid="iub2356-aff-0008">
<sup>8</sup>
</xref></contrib><contrib id="iub2356-cr-0010" contrib-type="author"><name><surname>Teimoori</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="iub2356-aff-0009">
<sup>9</sup>
</xref></contrib><contrib id="iub2356-cr-0011" contrib-type="author"><name><surname>Tari</surname><given-names>Kamran</given-names></name><xref ref-type="aff" rid="iub2356-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="iub2356-aff-0010">
<sup>10</sup>
</xref></contrib><contrib id="iub2356-cr-0012" contrib-type="author"><name><surname>Salari</surname><given-names>Mehdi</given-names></name><xref ref-type="aff" rid="iub2356-aff-0002">
<sup>2</sup>
</xref><xref ref-type="aff" rid="iub2356-aff-0010">
<sup>10</sup>
</xref></contrib><contrib id="iub2356-cr-0013" contrib-type="author"><name><surname>Ghiasvand</surname><given-names>Sima</given-names></name><xref ref-type="aff" rid="iub2356-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iub2356-cr-0014" contrib-type="author"><name><surname>Kazemi</surname><given-names>Sima</given-names></name><xref ref-type="aff" rid="iub2356-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iub2356-cr-0015" contrib-type="author"><name><surname>Yousefimashouf</surname><given-names>Rasoul</given-names></name><xref ref-type="aff" rid="iub2356-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="iub2356-cr-0016" contrib-type="author" corresp="yes"><name><surname>Keyvani</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="iub2356-aff-0007">
<sup>7</sup>
</xref><address><email>H.keyvani@iums.ac.ir</email></address></contrib><contrib id="iub2356-cr-0017" contrib-type="author" corresp="yes"><name><surname>Karampoor</surname><given-names>Sajad</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3716-8096</contrib-id><xref ref-type="aff" rid="iub2356-aff-0007">
<sup>7</sup>
</xref><address><email>sajadkarampour1987@gmail.com</email></address></contrib></contrib-group><aff id="iub2356-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Microbiology</named-content>
<institution>School of Medicine, Hamadan University of Medical Sciences</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Student Research Committee</named-content>
<institution>Hamadan University of Medical Sciences</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Faculty of Pharmacy</named-content>
<institution>Iran University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Faculty of Medicine</named-content>
<institution>Iran University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">School of Basic Sciences</named-content>
<institution>Ale&#x02010;Taha Institute of Higher Education</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0006">
<label><sup>6</sup></label>
<institution>Alnahrain University College of Medicine</institution>
<country country="IQ">Iraq</country>
</aff><aff id="iub2356-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">Department of Virology</named-content>
<institution>School of Medicine, Iran University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0008">
<label><sup>8</sup></label>
<named-content content-type="organisation-division">Department of Microbiology</named-content>
<institution>School of Medicine, Iran University of Medical Sciences</institution>
<city>Tehran</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0009">
<label><sup>9</sup></label>
<named-content content-type="organisation-division">Department of Virology</named-content>
<institution>School of Medicine, Hamadan University of Medical Sciences</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><aff id="iub2356-aff-0010">
<label><sup>10</sup></label>
<named-content content-type="organisation-division">Department of Environmental Health Engineering</named-content>
<institution>Hamadan University of Medical Sciences</institution>
<city>Hamadan</city>
<country country="IR">Iran</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Sajad Karampoor, Ph.D. of Medical Virology, Department of virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.<break/>
Email: <email>sajadkarampour1987@gmail.com</email><break/>
Rasoul Mirzaei, Ph.D. of Medical Microbiology, Department of Medical Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.<break/>
Email: <email>rasul.micro92@gmail.com</email><break/>
Hossein Keyvani, Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.<break/>
Email: <email>H.keyvani@iums.ac.ir</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>8</month><year>2020</year></pub-date><elocation-id>10.1002/iub.2356</elocation-id><history><date date-type="received"><day>16</day><month>6</month><year>2020</year></date><date date-type="rev-recd"><day>11</day><month>7</month><year>2020</year></date><date date-type="accepted"><day>12</day><month>7</month><year>2020</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2020 International Union of Biochemistry and Molecular Biology <copyright-statement>--><copyright-statement content-type="article-copyright">&#x000a9; 2020 International Union of Biochemistry and Molecular Biology</copyright-statement><license><license-p>This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:IUB-9999-na.pdf"/><abstract><title>Abstract</title><p>The pandemic coronavirus disease 2019 (COVID&#x02010;19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS&#x02010;CoV&#x02010;2), has affected millions of people worldwide. To date, there are no proven effective therapies for this virus. Efforts made to develop antiviral strategies for the treatment of COVID&#x02010;19 are underway. Respiratory viral infections, such as influenza, predispose patients to co&#x02010;infections and these lead to increased disease severity and mortality. Numerous types of antibiotics such as azithromycin have been employed for the prevention and treatment of bacterial co&#x02010;infection and secondary bacterial infections in patients with a viral respiratory infection (e.g., SARS&#x02010;CoV&#x02010;2). Although antibiotics do not directly affect SARS&#x02010;CoV&#x02010;2, viral respiratory infections often result in bacterial pneumonia. It is possible that some patients die from bacterial co&#x02010;infection rather than virus itself. To date, a considerable number of bacterial strains have been resistant to various antibiotics such as azithromycin, and the overuse could render those or other antibiotics even less effective. Therefore, bacterial co&#x02010;infection and secondary bacterial infection are considered critical risk factors for the severity and mortality rates of COVID&#x02010;19. Also, the antibiotic&#x02010;resistant as a result of overusing must be considered. In this review, we will summarize the bacterial co&#x02010;infection and secondary bacterial infection in some featured respiratory viral infections, especially COVID&#x02010;19.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="iub2356-kwd-0001">antibiotic</kwd><kwd id="iub2356-kwd-0002">bacterial co&#x02010;infection</kwd><kwd id="iub2356-kwd-0003">COVID&#x02010;19</kwd><kwd id="iub2356-kwd-0004">SARS&#x02010;CoV&#x02010;2</kwd><kwd id="iub2356-kwd-0005">viral infection</kwd></kwd-group><counts><fig-count count="1"/><table-count count="4"/><page-count count="15"/><word-count count="11916"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>edited-state</meta-name><meta-value>corrected-proof</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.8.7 mode:remove_FC converted:19.08.2020</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="self-citation" id="iub2356-cit-9001">
<string-name>
<surname>Mirzaei</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Goodarzi</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Asadi</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Bacterial co&#x02010;infections with <styled-content style="fixed-case" toggle="no">SARS&#x02010;CoV</styled-content>&#x02010;2</article-title>. <source xml:lang="en">IUBMB Life</source>. <year>2020</year>;<fpage>1</fpage>&#x02013;<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/iub.2356</pub-id>
</mixed-citation>
</p></notes></front><body id="iub2356-body-0001"><def-list list-content="abbreviations" id="iub2356-lp-0001"><title>Abbreviations</title><def-item><term id="iub2356-li-0027">AMPs</term><def id="iub2356-li-0028"><p>antimicrobial peptides</p></def></def-item><def-item><term id="iub2356-li-0015">CCL2</term><def id="iub2356-li-0016"><p>C&#x02010;C Motif Chemokine Ligand 2</p></def></def-item><def-item><term id="iub2356-li-0001">COVID&#x02010;19</term><def id="iub2356-li-0002"><p>coronavirus disease 2019</p></def></def-item><def-item><term id="iub2356-li-0007">HCoV</term><def id="iub2356-li-0008"><p>human coronavirus</p></def></def-item><def-item><term id="iub2356-li-0055">HCoV&#x02010;NL63</term><def id="iub2356-li-0056"><p>Human coronavirus NL63</p></def></def-item><def-item><term id="iub2356-li-0017">ICAM&#x02010;1</term><def id="iub2356-li-0018"><p>intercellular adhesion molecule 1</p></def></def-item><def-item><term id="iub2356-li-0013">IFNs</term><def id="iub2356-li-0014"><p>interferons</p></def></def-item><def-item><term id="iub2356-li-0025">IL</term><def id="iub2356-li-0026"><p>interleukin</p></def></def-item><def-item><term id="iub2356-li-0031">IP&#x02010;10</term><def id="iub2356-li-0032"><p>interferon&#x02010;&#x003b3;&#x02010;inducible protein&#x02010;10</p></def></def-item><def-item><term id="iub2356-li-0035">IRF&#x02010;3</term><def id="iub2356-li-0036"><p>interferon regulatory factor 3</p></def></def-item><def-item><term id="iub2356-li-0041">MAVS</term><def id="iub2356-li-0042"><p>mitochondrial antiviral&#x02010;signaling</p></def></def-item><def-item><term id="iub2356-li-0033">MCP&#x02010;1</term><def id="iub2356-li-0034"><p>monocyte chemoattractant protein&#x02010;1</p></def></def-item><def-item><term id="iub2356-li-0049">MDA5</term><def id="iub2356-li-0050"><p>RIG&#x02010;1/melanoma differentiation&#x02010;associated gene 5</p></def></def-item><def-item><term id="iub2356-li-0009">MERS</term><def id="iub2356-li-0010"><p>Middle East Respiratory Syndrome&#x02010;related coronavirus</p></def></def-item><def-item><term id="iub2356-li-0023">NADPH</term><def id="iub2356-li-0024"><p>nicotinamide adenine dinucleotide phosphate</p></def></def-item><def-item><term id="iub2356-li-0021">NTHI</term><def id="iub2356-li-0022"><p>non&#x02010;typeable <italic>H. influenzae</italic>
</p></def></def-item><def-item><term id="iub2356-li-0053">PERK</term><def id="iub2356-li-0054"><p>PKR&#x02010;like endoplasmic reticulum kinase</p></def></def-item><def-item><term id="iub2356-li-0051">PKR</term><def id="iub2356-li-0052"><p>protein kinase R</p></def></def-item><def-item><term id="iub2356-li-0029">REG3B</term><def id="iub2356-li-0030"><p>Regenerating Islet Derived Protein 3 Beta</p></def></def-item><def-item><term id="iub2356-li-0039">RIG&#x02010;I</term><def id="iub2356-li-0040"><p>retinoic acid&#x02010;inducible gene 1</p></def></def-item><def-item><term id="iub2356-li-0005">SARS</term><def id="iub2356-li-0006"><p>severe acute respiratory syndrome</p></def></def-item><def-item><term id="iub2356-li-0003">SARS&#x02010;CoV&#x02010;2</term><def id="iub2356-li-0004"><p>Severe Acute Respiratory Syndrome Coronavirus 2</p></def></def-item><def-item><term id="iub2356-li-0037">STAT1</term><def id="iub2356-li-0038"><p>signal transducer and activator of transcription 1</p></def></def-item><def-item><term id="iub2356-li-0045">TANK</term><def id="iub2356-li-0046"><p>TRAF Family Member Associated NFKB Activator</p></def></def-item><def-item><term id="iub2356-li-0057">TB</term><def id="iub2356-li-0058"><p>tuberculosis</p></def></def-item><def-item><term id="iub2356-li-0011">TGF&#x02010;&#x003b2;</term><def id="iub2356-li-0012"><p>transforming growth factor&#x02010;beta</p></def></def-item><def-item><term id="iub2356-li-0047">TLR&#x02010;3</term><def id="iub2356-li-0048"><p>Toll&#x02010;like receptor 3</p></def></def-item><def-item><term id="iub2356-li-0043">TRAF3</term><def id="iub2356-li-0044"><p>TNF Receptor Associated Factor 3</p></def></def-item><def-item><term id="iub2356-li-0019">T4P</term><def id="iub2356-li-0020"><p>Type 4 pilus</p></def></def-item><def-item><term id="iub2356-li-0059">WGMs</term><def id="iub2356-li-0060"><p>whole&#x02010;genome metagenomics</p></def></def-item></def-list><sec id="iub2356-sec-0001"><label>1</label><title>INTRODUCTION</title><p>The coronavirus disease 2019 (COVID&#x02010;19) is an infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS&#x02010;CoV&#x02010;2) that was first identified in December 2019 in Wuhan, China, and is currently circulating throughout the world.<xref rid="iub2356-bib-0001" ref-type="ref">
<sup>1</sup>
</xref> By July 5, 2020, more than 11,125,245 million cases have been diagnosed in 216 countries, and more than 528,204 deaths have been reported.<xref rid="iub2356-bib-0002" ref-type="ref">
<sup>2</sup>
</xref> The ongoing COVID&#x02010;19 pandemic highlights the critical need for rapid development of vaccines and antiviral treatments to reduce the number of hospitalizations and deaths caused by this new dangerous coronavirus.<xref rid="iub2356-bib-0003" ref-type="ref">
<sup>3</sup>
</xref> Co&#x02010;infections and superinfections are common in respiratory viral infections.<xref rid="iub2356-bib-0004" ref-type="ref">
<sup>4</sup>
</xref>, <xref rid="iub2356-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> According to the laboratory, clinical, and epidemiological studies, secondary or bacterial co&#x02010;infections with other viruses can significantly increase the mortality rate in patients infected with viral infections.<xref rid="iub2356-bib-0006" ref-type="ref">
<sup>6</sup>
</xref>, <xref rid="iub2356-bib-0007" ref-type="ref">
<sup>7</sup>
</xref> It has previously documented that the mortality rate of viral infections can be influenced by different factors, such as bacterial co&#x02010;infection.<xref rid="iub2356-bib-0008" ref-type="ref">
<sup>8</sup>
</xref>, <xref rid="iub2356-bib-0009" ref-type="ref">
<sup>9</sup>
</xref>, <xref rid="iub2356-bib-0010" ref-type="ref">
<sup>10</sup>
</xref> For instance, influenza&#x02010;related bacterial infections contribute to severe illness and mortality during the epidemic and seasonal influenza outbreaks.<xref rid="iub2356-bib-0011" ref-type="ref">
<sup>11</sup>
</xref> Some influenza&#x02010;related bacterial species include <italic>Streptococcus pyogenes</italic>, <italic>Neisseria meningitidis</italic>, <italic>Moraxella catarrhalis</italic>, <italic>Streptococcus pneumoniae</italic>, <italic>Haemophilus influenzae</italic>, and <italic>Staphylococcus aureus</italic>.<xref rid="iub2356-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>, <xref rid="iub2356-bib-0012" ref-type="ref">
<sup>12</sup>
</xref>, <xref rid="iub2356-bib-0013" ref-type="ref">
<sup>13</sup>
</xref>, <xref rid="iub2356-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>, <xref rid="iub2356-bib-0015" ref-type="ref">
<sup>15</sup>
</xref>, <xref rid="iub2356-bib-0016" ref-type="ref">
<sup>16</sup>
</xref>, <xref rid="iub2356-bib-0017" ref-type="ref">
<sup>17</sup>
</xref>, <xref rid="iub2356-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> The mechanisms of severe complications caused by influenza&#x02010;bacterial co&#x02010;infections mainly include a lack of effective immune response as well as pathogenic synergy.<xref rid="iub2356-bib-0005" ref-type="ref">
<sup>5</sup>
</xref> Although multiple microbial agents can cause acute lower respiratory tract infections, in most cases, the disease is caused by viruses and bacteria at the same time.<xref rid="iub2356-bib-0019" ref-type="ref">
<sup>19</sup>
</xref> Secondary and bacterial co&#x02010;infections with pandemics and viral epidemics have irreversible consequences, especially in high&#x02010;risk groups, including those with immunodeficiency or immunosuppression.<xref rid="iub2356-bib-0020" ref-type="ref">
<sup>20</sup>
</xref>
</p><p>Emerging evidence suggests that the number of patients with COVID&#x02010;19 diagnosed with bacterial co&#x02010;infections during hospitalization periods is increasingly raised.<xref rid="iub2356-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>, <xref rid="iub2356-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>, <xref rid="iub2356-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> The source and specific nature of these infections are yet to be fully explored, but there is some evidence suggesting that multidrug&#x02010;resistant bacteria are among the pathogens that are thought to be responsible for the development of these infections.<xref rid="iub2356-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>, <xref rid="iub2356-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>, <xref rid="iub2356-bib-0023" ref-type="ref">
<sup>23</sup>
</xref> Patients vulnerable to viral lung infections, such as influenza, severe acute respiratory syndrome (SARS), and COVID&#x02010;19 are the greatest risk to be co&#x02010;infected with superbugs.<xref rid="iub2356-bib-0021" ref-type="ref">
<sup>21</sup>
</xref>, <xref rid="iub2356-bib-0022" ref-type="ref">
<sup>22</sup>
</xref>, <xref rid="iub2356-bib-0023" ref-type="ref">
<sup>23</sup>
</xref>, <xref rid="iub2356-bib-0024" ref-type="ref">
<sup>24</sup>
</xref>, <xref rid="iub2356-bib-0025" ref-type="ref">
<sup>25</sup>
</xref> For example, the 2009 H1N1 influenza pandemic caused approximately 300,000 deaths around the world in which 30&#x02013;55% of cases die of bacterial pneumonia.<xref rid="iub2356-bib-0026" ref-type="ref">
<sup>26</sup>
</xref>, <xref rid="iub2356-bib-0027" ref-type="ref">
<sup>27</sup>
</xref> It is now known that viral infections can weaken the host immunity, paving the way for the development of viral&#x02010;bacterial co&#x02010;infection.<xref rid="iub2356-bib-0028" ref-type="ref">
<sup>28</sup>
</xref>, <xref rid="iub2356-bib-0029" ref-type="ref">
<sup>29</sup>
</xref> The new coronavirus, COVID&#x02010;19, is another example of this fact as most of the hospitalized patients with COVID&#x02010;19 acquired a secondary bacterial infection.<xref rid="iub2356-bib-0030" ref-type="ref">
<sup>30</sup>
</xref>, <xref rid="iub2356-bib-0031" ref-type="ref">
<sup>31</sup>
</xref>, <xref rid="iub2356-bib-0032" ref-type="ref">
<sup>32</sup>
</xref> In some severe form of SARS&#x02010;CoV&#x02010;2, patients exhibited increased levels of infection&#x02010;related biomarkers and inflammatory cytokines, suggesting potential bacterial co&#x02010;infection as a result of the dysregulated immune system.<xref rid="iub2356-bib-0033" ref-type="ref">
<sup>33</sup>
</xref> Besides, the emergence of antibiotic resistance could be an additional burden for the health care system as co&#x02010;infection with coronavirus and pneumonia stretches health care units beyond their capabilities and resources. Understanding the mechanism underlying the synergy between Covid&#x02010;19 and bacteria paves the way for the discovery of novel therapeutic agents to prevent the mortality rate in patients co&#x02010;infected with COVID&#x02010;19 and bacteria. In the current situation, appropriate and systematic analysis of COVID&#x02010;19 patients diagnosed with bacterial co&#x02010;infection should be implemented to choose proper antibiotics to increase the survival of patients and limit the spread of drug&#x02010;resistant bacteria. The use of rapid diagnostic tools and methods promoting the prescription of effective narrow&#x02010;spectrum antibiotics should be taken into account. In this review, we will summarize the current data available for bacterial infections in patients with COVID&#x02010;19.</p><sec id="iub2356-sec-0002"><label>1.1</label><title>Bacterial co&#x02010;infection with viral respiratory infections</title><p>Viral pneumonia and lower respiratory tract infections are well characterized in adult patients, including those diagnosed with severe forms of viral infection.<xref rid="iub2356-bib-0034" ref-type="ref">
<sup>34</sup>
</xref> Most viral lower respiratory tract infections seem to be acquired in the community and considered a leading cause of infection in patients who undergo mechanical ventilation.<xref rid="iub2356-bib-0034" ref-type="ref">
<sup>34</sup>
</xref> The most common cases diagnosed with bacterial co&#x02010;infection with viral infections are seen in those infected with influenza virus.<xref rid="iub2356-bib-0027" ref-type="ref">
<sup>27</sup>
</xref> The oldest report of bacterial infections that occurred simultaneously or shortly after influenza is related to the 1918 Influenza pandemic, in which most deaths occurred as a result of co&#x02010;infection with infectious bacteria.<xref rid="iub2356-bib-0035" ref-type="ref">
<sup>35</sup>
</xref> Also, the H1N1 Influenza pandemic in 2009 was complicated by bacterial pneumonia in 4&#x02013;33% of hospitalized patients.<xref rid="iub2356-bib-0036" ref-type="ref">
<sup>36</sup>
</xref>, <xref rid="iub2356-bib-0037" ref-type="ref">
<sup>37</sup>
</xref>, <xref rid="iub2356-bib-0038" ref-type="ref">
<sup>38</sup>
</xref> Bacterial&#x02010;viral co&#x02010;infection is not restricted to influenza and also caused by other respiratory viruses, such as parainfluenza virus, respiratory syncytial virus, adenovirus, rhinovirus, and human metapneumovirus.<xref rid="iub2356-bib-0034" ref-type="ref">
<sup>34</sup>
</xref>, <xref rid="iub2356-bib-0039" ref-type="ref">
<sup>39</sup>
</xref>, <xref rid="iub2356-bib-0040" ref-type="ref">
<sup>40</sup>
</xref> Despite the discovery of antibiotics and viral vaccines in 1918&#x02013;1957, the mortality rate, resulting from secondary bacterial pneumonia remained a major problem. The mortality rate seems to be still growing mostly because of the rapid rate of aging in the human population.<xref rid="iub2356-bib-0041" ref-type="ref">
<sup>41</sup>
</xref>, <xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref>
</p><p>Although viruses are commonly responsible for the development of acute upper and lower respiratory infections, in most cases patients may be infected by both bacterial and viral pathogens; however, the clinical manifestations at the early stages of the disease would not be nosologically distinguishable for physicians to differentially diagnose viral from a bacterial infection.<xref rid="iub2356-bib-0043" ref-type="ref">
<sup>43</sup>
</xref> Recently, a group of respiratory emerging viruses has been identified, such as human coronavirus (HCoV), NL63, human bocavirus, influenza viruses' type H1N1 and H5N1, SARS, Middle East Respiratory Syndrome&#x02010;related coronavirus (MERS), and Covid&#x02010;19.<xref rid="iub2356-bib-0044" ref-type="ref">
<sup>44</sup>
</xref>, <xref rid="iub2356-bib-0045" ref-type="ref">
<sup>45</sup>
</xref>, <xref rid="iub2356-bib-0046" ref-type="ref">
<sup>46</sup>
</xref>, <xref rid="iub2356-bib-0047" ref-type="ref">
<sup>47</sup>
</xref>, <xref rid="iub2356-bib-0048" ref-type="ref">
<sup>48</sup>
</xref> In children, atypical bacterial pathogens, such as <italic>Legionella pneumophila</italic>, <italic>Mycoplasma pneumoniae</italic>, and <italic>Chlamydophila pneumoniae</italic> include the majority of infectious agents that cause mild, moderate, or even severe forms of acute respiratory infections.<xref rid="iub2356-bib-0049" ref-type="ref">
<sup>49</sup>
</xref>, <xref rid="iub2356-bib-0050" ref-type="ref">
<sup>50</sup>
</xref> Bacterial co&#x02010;infections with respiratory viral pathogens are very common, often through synergistic interaction among viruses such as influenza virus, and bacterial pathogens and the host immune system of the human being; nevertheless, the interaction between viruses and unusual bacteria is not yet fully understood.<xref rid="iub2356-bib-0050" ref-type="ref">
<sup>50</sup>
</xref>, <xref rid="iub2356-bib-0051" ref-type="ref">
<sup>51</sup>
</xref> These secondary infections predominantly involve a specific group of bacterial pathogens, such as <italic>S. aureus</italic>, <italic>S. pneumoniae</italic>, <italic>S. pyogenes</italic>, and <italic>H. influenzae</italic>.<xref rid="iub2356-bib-0011" ref-type="ref">
<sup>11</sup>
</xref>, <xref rid="iub2356-bib-0012" ref-type="ref">
<sup>12</sup>
</xref>, <xref rid="iub2356-bib-0013" ref-type="ref">
<sup>13</sup>
</xref>, <xref rid="iub2356-bib-0014" ref-type="ref">
<sup>14</sup>
</xref>, <xref rid="iub2356-bib-0015" ref-type="ref">
<sup>15</sup>
</xref>, <xref rid="iub2356-bib-0016" ref-type="ref">
<sup>16</sup>
</xref>, <xref rid="iub2356-bib-0017" ref-type="ref">
<sup>17</sup>
</xref>, <xref rid="iub2356-bib-0018" ref-type="ref">
<sup>18</sup>
</xref> A complete list of bacterial co&#x02010;infections with viral pathogens is depicted in Table <xref rid="iub2356-tbl-0001" ref-type="table">1</xref>.</p><table-wrap id="iub2356-tbl-0001" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 1</label><caption><p>Common respiratory viral&#x02010;bacterial coinfections and their associated clinical infections in human</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Viral infection</th><th align="left" valign="bottom" rowspan="1" colspan="1">Bacterial coinfection</th><th align="left" valign="bottom" rowspan="1" colspan="1">Clinical infection</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Influenza</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Staphylococcus aureus</italic>, MRSA</td><td align="left" valign="top" rowspan="1" colspan="1">Community&#x02010;acquired pneumonia,</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0018" ref-type="ref">18</xref>, <xref rid="iub2356-bib-0052" ref-type="ref">52</xref>, <xref rid="iub2356-bib-0053" ref-type="ref">53</xref>, <xref rid="iub2356-bib-0054" ref-type="ref">54</xref>, <xref rid="iub2356-bib-0055" ref-type="ref">55</xref>, <xref rid="iub2356-bib-0056" ref-type="ref">56</xref>, <xref rid="iub2356-bib-0057" ref-type="ref">57</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Streptococcus pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumococcal pneumonia, sepsis, meningitis, otitis media</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0058" ref-type="ref">58</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Streptococcus pyogenes</italic> (group A streptococci)</td><td align="left" valign="top" rowspan="1" colspan="1">Sepsis, pleural empyema</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0015" ref-type="ref">15</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Haemophilus influenzae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0059" ref-type="ref">59</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Moraxella catarrhalis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia and bacteremia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0060" ref-type="ref">60</xref>, <xref rid="iub2356-bib-0061" ref-type="ref">61</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Neisseria meningitidis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Meningococcemia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0062" ref-type="ref">62</xref>, <xref rid="iub2356-bib-0063" ref-type="ref">63</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Chlamydophila pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0064" ref-type="ref">64</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Mycoplasma pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0064" ref-type="ref">64</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Legionella pneumophila</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>Pseudomonas aeruginosa</italic>, <italic>Acinetobacter baumannii</italic>, <italic>Burkholderia cepacia</italic>, <italic>Enterobacter aerogenes</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0057" ref-type="ref">57</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Metapneumovirus</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Haemophilus influenzae</italic>, enterococcus spp, <italic>N. meningitidis</italic> group B, Brucella spp, <italic>Streptococcus pyogenes</italic>, <italic>Streptococcus pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Acute otitis media, pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0065" ref-type="ref">65</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Respiratory syncytial virus</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Pseudomonas aeruginosa</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory infections in cystic fibrosis patients</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0066" ref-type="ref">66</xref>, <xref rid="iub2356-bib-0067" ref-type="ref">67</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adenovirus</td><td align="left" valign="top" rowspan="1" colspan="1">Non&#x02010;typeable <italic>Haemophilus influenzae</italic>, <italic>Chlamydia trachomatis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia or acute otitis media</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0068" ref-type="ref">68</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Parainfluenza</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>
<italic>Streptococcus pneumonia</italic>, <italic>Streptococcus agalactiae</italic>,</p>
<p>
<italic>Haemophilus influenza</italic>
</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Acute otitis media, pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0069" ref-type="ref">69</xref>, <xref rid="iub2356-bib-0070" ref-type="ref">70</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rhinovirus</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>
<italic>Streptococcus pneumonia</italic>,</p>
<p>
<italic>Mycoplasma</italic>
</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0050" ref-type="ref">50</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Staphylococcus aureus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory complications</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0071" ref-type="ref">71</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SARS</td><td align="left" valign="top" rowspan="1" colspan="1">
<p>
<italic>Chlamydophila pneumonia</italic>
</p>
<p>
<italic>Mycoplasma pneumonia</italic>
</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0072" ref-type="ref">72</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">MRSA</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0073" ref-type="ref">73</xref>, <xref rid="iub2356-bib-0074" ref-type="ref">74</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MERS</td><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Mycobacterium tuberculosis</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Immune suppression and augment the infection of each other</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0075" ref-type="ref">75</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">
<p>
<italic>Mycoplasma</italic> spp.</p>
<p>
<italic>Legionella</italic>
</p>
<p>
<italic>Chlamydia</italic> spp.</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0076" ref-type="ref">76</xref>
</td></tr></tbody></table><table-wrap-foot id="iub2356-ntgp-0001"><fn id="iub2356-note-0001"><p>Abbreviations: MERS, Middle East respiratory syndrome; MRSA, methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic>; SARS, severe acute respiratory syndrome.</p></fn></table-wrap-foot></table-wrap></sec><sec id="iub2356-sec-0003"><label>1.2</label><title>Viral predisposition to bacterial co&#x02010;infection in the respiratory tract</title><p>Commonly, viral infection can destroy histologically and functionally the respiratory tract of individuals upon viral spread.<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref> Depending on the type of the virus, the histopathological outcomes could be relatively different from mild types to severe ones. These detrimental changes include altered mucus secretion, cell death, hyperplasia, decreased mucosal clearance, reduced oxygen exchange, and impaired surfactant secretion.<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref>, <xref rid="iub2356-bib-0077" ref-type="ref">
<sup>77</sup>
</xref> Each of these effects is caused by various molecular mechanisms, depending on the virus, bacterial species, as well as the degree of the host immune reaction to either a bacterium or virus.<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref> It has been noted that viral infections promote bacterial colonization of the airway through a variety of mechanisms.<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref> Peltola and colleagues found that influenza viruses can enhance the colonization of the nasopharynx by <italic>S. pneumoniae</italic> bacterium, however, only particular subtypes were found to mediate the development of bacterial otitis media and sinusitis.<xref rid="iub2356-bib-0078" ref-type="ref">
<sup>78</sup>
</xref> These data explain why the rate of bacterial infection is high in influenza seasons.<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref> The neuraminidase enzyme of the influenza virus has been found to be presented on the host cell receptors, and they are employed for the adherence of bacteria due to its sialidase ability that changes the carbohydrate moieties on the host epithelial cells.<xref rid="iub2356-bib-0077" ref-type="ref">
<sup>77</sup>
</xref>, <xref rid="iub2356-bib-0079" ref-type="ref">
<sup>79</sup>
</xref> This enzyme is also capable of increasing the possibility of bacterial adherence to the host cells through the stimulation of transforming growth factor&#x02010;beta (TGF&#x02010;&#x003b2;) which triggers the up&#x02010;regulation of integrins and fibronectin. Integrins and fibronectin have been shown to act as receptors for bacteria.<xref rid="iub2356-bib-0080" ref-type="ref">
<sup>80</sup>
</xref> Besides, interferons (IFNs) induction of by influenza virus can cause reduced C&#x02010;C Motif Chemokine Ligand 2 (CCL2) expression resulting in failed macrophages recruitment that necessary for clearance of pneumococcal cells thereby enhance the colonization of <italic>S. pneumoniae</italic> in vivo.<xref rid="iub2356-bib-0081" ref-type="ref">
<sup>81</sup>
</xref> Also, it has been found that the influenza virus predisposes the host to develop pneumonia caused by <italic>S. aureus</italic> where viral and bacterial loads are increased during co&#x02010;infection.<xref rid="iub2356-bib-0052" ref-type="ref">
<sup>52</sup>
</xref> It has been hypothesized that viral load is increased following bacterial co&#x02010;infection because of increased shedding rate of the virus from infected host cells; however, bacterial loads would be elevated as a result of impaired function of alveolar macrophages.<xref rid="iub2356-bib-0082" ref-type="ref">
<sup>82</sup>
</xref>
</p><p>Additionally, other upper respiratory tract viruses increase the adherence ability of bacterial pathogens to primary and immortalized epithelial cells with particular differences. Such differences are determined by the types of epithelial cells and their response to parainfluenza virus&#x02010;3, respiratory syncytial virus, and/or influenza virus.<xref rid="iub2356-bib-0083" ref-type="ref">
<sup>83</sup>
</xref> Novotny et al<xref rid="iub2356-bib-0084" ref-type="ref">
<sup>84</sup>
</xref> showed that adenovirus and respiratory syncytial virus stimulated the expression of intercellular adhesion molecule 1 (ICAM&#x02010;1) by primary respiratory tract epithelial cells. ICAM1 acts as a receptor for Type 4 pilus (T4P) of non&#x02010;typeable <italic>H. influenzae</italic> (NTHI), thus promoting the binding of this pathogen to cells expressing this molecule. Also, respiratory syncytial virus infection increases the binding ability of <italic>P. aeruginosa</italic> to normal epithelial cells, as well as cells affected by cystic fibrosis. Such phenomena have been frequently employed by other bacteria to increase their virulence to infect the cells.<xref rid="iub2356-bib-0066" ref-type="ref">
<sup>66</sup>
</xref> Studies have indicated that, following the infection with the respiratory syncytial virus, the rate of the binding of <italic>S. pneumoniae</italic> serotypes epithelial cells is increased by 2&#x02013;10 folds.<xref rid="iub2356-bib-0085" ref-type="ref">
<sup>85</sup>
</xref> Similarly, the antibody titers against <italic>S. pneumoniae</italic> are elevated in the nasopharynx when the cells co&#x02010;infected with the respiratory syncytial virus, rhinovirus, and community&#x02010;acquired pneumonia.<xref rid="iub2356-bib-0086" ref-type="ref">
<sup>86</sup>
</xref> The higher degree of colonization of nasopharynx with <italic>S. pneumoniae</italic> is also found when the individuals are co&#x02010;infected with viral upper respiratory tract infection or human immunodeficiency virus infection.<xref rid="iub2356-bib-0087" ref-type="ref">
<sup>87</sup>
</xref>
</p><p>Bacterial and viral co&#x02010;infection can alter some properties of the host mucosal immunity, leading to the failure in controlling the replication of bacteria in this site.<xref rid="iub2356-bib-0088" ref-type="ref">
<sup>88</sup>
</xref>, <xref rid="iub2356-bib-0089" ref-type="ref">
<sup>89</sup>
</xref> Some key findings are discussed here, including the influence of viral infection on phagocytic activity. The reduction of alveolar macrophages by the influenza virus facilitates bacterial co&#x02010;infection.<xref rid="iub2356-bib-0088" ref-type="ref">
<sup>88</sup>
</xref>, <xref rid="iub2356-bib-0090" ref-type="ref">
<sup>90</sup>
</xref> Several lines of evidence demonstrated that 90% of resident alveolar macrophages were lost in the early weeks after influenza infection through tracking dye&#x02010;labeled alveolar macrophages,<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref> whereas 95% of the initial bacterial inoculum was eliminated during 3 hr by alveolar macrophages in non&#x02010;influenza inoculated hosts. Notably, in those cells co&#x02010;infected with influenza virus about 50% of the bacterial inoculum remained recoverable.<xref rid="iub2356-bib-0042" ref-type="ref">
<sup>42</sup>
</xref> Also, it has been suggested that phagocyte activity, along with the cell proliferation could be influenced by viral infection. The infection of alveolar macrophages with influenza causes a marked decrease in the level of cytokines and chemokines, leading to decreased rates of recruitment and stimulation of neutrophils.<xref rid="iub2356-bib-0088" ref-type="ref">
<sup>88</sup>
</xref> It may also suppress the phagocytic bacterial clearance mediated to nicotinamide adenine dinucleotide phosphate (NADPH), thereby increasing the susceptibility to secondary bacterial infection.<xref rid="iub2356-bib-0091" ref-type="ref">
<sup>91</sup>
</xref> As mentioned earlier, the dysregulation of pro&#x02010;inflammatory cytokine&#x02010;induced by viral infection has been shown to play an essential role in the susceptibility of the cells to secondary bacterial infection. It is now known that type 1 IFNs have antiviral and immune&#x02010;stimulatory properties and could have detrimental effects on human cells when their expression is inappropriate and excessive. It has been reported that IFNs play a fundamental role in the production of anti&#x02010;inflammatory cytokines, such as interleukin (IL)&#x02010;10 and IL&#x02010;6, as well as the inhibition of proinflammatory cytokines, linking the innate immunity to adaptive immune responses, such as IL&#x02010;17 and IL&#x02010;23. They also decrease the activity of macrophages, dendritic cells, natural killer cells, along with the number of CD4&#x02010; and CD8&#x02010;positive T cells, leading to the impaired eradication of bacterial co&#x02010;infection.<xref rid="iub2356-bib-0079" ref-type="ref">
<sup>79</sup>
</xref>, <xref rid="iub2356-bib-0092" ref-type="ref">
<sup>92</sup>
</xref>, <xref rid="iub2356-bib-0093" ref-type="ref">
<sup>93</sup>
</xref>, <xref rid="iub2356-bib-0094" ref-type="ref">
<sup>94</sup>
</xref>
</p><p>Also, there are a number of mechanisms that are independent of the phagocytosis process by which viral host infection can predispose the human body to secondary bacterial co&#x02010;infection. The production of antimicrobial peptides (AMPs), such as lipocalin&#x02010;2, cathelicidin, Regenerating Islet Derived Protein 3 Beta (REG3B), calprotectin, may be dysregulated by upper respiratory tract viruses.<xref rid="iub2356-bib-0094" ref-type="ref">
<sup>94</sup>
</xref> The respiratory syncytial virus infection is able to diminish the expression of human &#x003b2;&#x02010;defensin&#x02010;3 orthologue named chinchilla beta&#x02010;defensin 1 when used in vivo. Of note, con&#x02010;infection with the respiratory syncytial virus is capable of stimulating the viral load of <italic>Nontypeable Haemophilus influenzae</italic> (<italic>NTHi</italic>) in the nasopharynx by 10&#x02013;100 folds.<xref rid="iub2356-bib-0095" ref-type="ref">
<sup>95</sup>
</xref> The intranasal delivery of anti&#x02010; chinchilla beta&#x02010;defensin 1, human &#x003b2;&#x02010;defensin 3, or the recombinant form of chinchilla beta&#x02010;defensin 1 showed that the disruption of the availability of even a single innate immune effector could have a great impact on bacterial load since the viral infection has a critical in the loading of <italic>H. influenzae</italic> within the host airway.<xref rid="iub2356-bib-0095" ref-type="ref">
<sup>95</sup>
</xref> Some mechanisms by which viral respiratory infections may predispose patients to bacterial infections to include failure immune response, viral&#x02010;induced changes in epithelial cells, and the increased bacterial colonization<xref rid="iub2356-bib-0034" ref-type="ref">
<sup>34</sup>
</xref> and summarize of the potential mechanisms responsible for bacterial coinfection with viral respiratory infections is depicted in Table <xref rid="iub2356-tbl-0002" ref-type="table">2</xref>.</p><table-wrap id="iub2356-tbl-0002" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 2</label><caption><p>Summary of the potential mechanisms responsible for the bacterial coinfection with viral respiratory infections</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Mechanism</th><th align="left" valign="bottom" rowspan="1" colspan="1">Description</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Elevation in bacterial adherence due to viral infection</td><td align="left" valign="top" rowspan="1" colspan="1">Virus can modulate surface membrane receptors, thereby enhancing bacterial adhesion</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0016" ref-type="ref">16</xref>, <xref rid="iub2356-bib-0096" ref-type="ref">96</xref>, <xref rid="iub2356-bib-0097" ref-type="ref">97</xref>, <xref rid="iub2356-bib-0098" ref-type="ref">98</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell destruction by viral enzymes</td><td align="left" valign="top" rowspan="1" colspan="1">Viral enzymes destroy mucosal glycoproteins, mainly those inhibiting bacterial attachment</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0098" ref-type="ref">98</xref>, <xref rid="iub2356-bib-0099" ref-type="ref">99</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reduction of mucociliary clearance</td><td align="left" valign="top" rowspan="1" colspan="1">Virus can reduce mucociliary clearance leading to the decreased production of bactericidal materials</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0100" ref-type="ref">100</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reduction in chemotaxis</td><td align="left" valign="top" rowspan="1" colspan="1">Virus can decrease the chemotactic factors, leading to the reduced cell response to attacking organisms</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0101" ref-type="ref">101</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Direct effect on phagocytic and induction of post phagocytic alveolar macrophage functions</td><td align="left" valign="top" rowspan="1" colspan="1">Virus hinders or modifies a number of immune functions, such as phagosome&#x02010;lysosome fusion and intracellular killing</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0102" ref-type="ref">102</xref>, <xref rid="iub2356-bib-0103" ref-type="ref">103</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Induction of immature phagocytes</td><td align="left" valign="top" rowspan="1" colspan="1">Virus can disrupt macrophages and probably replace them with immature phagocytes</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0098" ref-type="ref">98</xref>, <xref rid="iub2356-bib-0104" ref-type="ref">104</xref>, <xref rid="iub2356-bib-0105" ref-type="ref">105</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reduction of surfactant levels</td><td align="left" valign="top" rowspan="1" colspan="1">Virus impairs the function of alveolar type&#x02010;2 pneumocyte</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0098" ref-type="ref">98</xref>, <xref rid="iub2356-bib-0106" ref-type="ref">106</xref>, <xref rid="iub2356-bib-0107" ref-type="ref">107</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Induction of dysbiosis in lower respiratory tract microbiome</td><td align="left" valign="top" rowspan="1" colspan="1">Microbiome dysbiosis can affect the immune response against respiratory viral infection</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0108" ref-type="ref">108</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dysregulation of the innate and adaptive immune responses</td><td align="left" valign="top" rowspan="1" colspan="1">Virus decreases the number of alveolar macrophages through the development of apoptosis</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0042" ref-type="ref">42</xref>, <xref rid="iub2356-bib-0088" ref-type="ref">88</xref>, <xref rid="iub2356-bib-0090" ref-type="ref">90</xref>, <xref rid="iub2356-bib-0091" ref-type="ref">91</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Modulation of apoptosis and inflammation</td><td align="left" valign="top" rowspan="1" colspan="1">Autophagy and apoptosis facilitates secondary bacterial pneumonia after viral infection</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0109" ref-type="ref">109</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Reduction of antibacterial immune function at the respiratory epithelium</td><td align="left" valign="top" rowspan="1" colspan="1">Respiratory viral infection leads to the predisposition to secondary bacterial infection via the deviation of the respiratory tract immune status</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0110" ref-type="ref">110</xref>, <xref rid="iub2356-bib-0111" ref-type="ref">111</xref>, <xref rid="iub2356-bib-0112" ref-type="ref">112</xref>, <xref rid="iub2356-bib-0113" ref-type="ref">113</xref>, <xref rid="iub2356-bib-0114" ref-type="ref">114</xref>, <xref rid="iub2356-bib-0115" ref-type="ref">115</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dysregulation of nutritional immunity</td><td align="left" valign="top" rowspan="1" colspan="1">Some viruses can subvert nutritional protection to promote bacterial infection</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0116" ref-type="ref">116</xref>, <xref rid="iub2356-bib-0117" ref-type="ref">117</xref>, <xref rid="iub2356-bib-0118" ref-type="ref">118</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Immunosuppression</td><td align="left" valign="top" rowspan="1" colspan="1">Immunosuppression is induced by several viruses such as HIV</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0119" ref-type="ref">119</xref>, <xref rid="iub2356-bib-0120" ref-type="ref">120</xref>, <xref rid="iub2356-bib-0121" ref-type="ref">121</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Synergism during viral/bacterial co&#x02010;infections</td><td align="left" valign="top" rowspan="1" colspan="1">Both viruses and bacteria play a role in the immunopathogenicity of co&#x02010;infection</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0008" ref-type="ref">8</xref>, <xref rid="iub2356-bib-0122" ref-type="ref">122</xref>, <xref rid="iub2356-bib-0123" ref-type="ref">123</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Release of planktonic bacteria from biofilms</td><td align="left" valign="top" rowspan="1" colspan="1">Viruses can manipulate many factors such as chemokines and hydrogen peroxide, thereby leading to the disruption of biofilm structure</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0042" ref-type="ref">42</xref>, <xref rid="iub2356-bib-0124" ref-type="ref">124</xref>, <xref rid="iub2356-bib-0125" ref-type="ref">125</xref>, <xref rid="iub2356-bib-0126" ref-type="ref">126</xref>
</td></tr></tbody></table><table-wrap-foot id="iub2356-ntgp-0002"><fn id="iub2356-note-0002"><p>Abbreviation: HIV, human immunodeficiency viruses.</p></fn></table-wrap-foot></table-wrap></sec><sec id="iub2356-sec-0004"><label>1.3</label><title>Coronaviruses influence on host immune system</title><p>The human immune reaction to SARS&#x02010;CoV&#x02010;2 infection is a two&#x02010;step reaction that during the non&#x02010;severe infection phase, a particular adaptive immune reaction is necessary to viral eradicate and prevent the disease from progressing to a severe phase.<xref rid="iub2356-bib-0127" ref-type="ref">
<sup>127</sup>
</xref>, <xref rid="iub2356-bib-0128" ref-type="ref">
<sup>128</sup>
</xref> Hence, approaches to increase immune reactions such as using anti&#x02010;serum and Pegylated IFN&#x003b1; are crucial at this phase.<xref rid="iub2356-bib-0127" ref-type="ref">
<sup>127</sup>
</xref>, <xref rid="iub2356-bib-0128" ref-type="ref">
<sup>128</sup>
</xref> To provide a protective immune reaction in the early phase, the host must be in a good general health condition and have a genetic background to be able to exhibit an acceptable antiviral reaction. Genetic diversity is well known to involve in particular changes in the host immune response to various microbial pathogens.</p><p>There is few information about the initial events in the process of virus elimination and inflammatory reactions during SARS&#x02010;CoV infection. However, the innate immune reactions is mediated to the adaptive immunity development and disease severity in SARS&#x02010;CoV.<xref rid="iub2356-bib-0129" ref-type="ref">
<sup>129</sup>
</xref> Of note, SARS&#x02010;CoV evolved escape mechanisms to avoid IFN responses in infected host cells. Besides, inflammatory reactions are regulated by inflammatory cytokines and chemokines such as IL&#x02010;6, interferon&#x02010;&#x003b3;&#x02010;inducible protein&#x02010;10 (IP&#x02010;10), monocyte chemoattractant protein&#x02010;1(MCP&#x02010;1) as well as the penetration of inflammatory cells such as macrophages into infected host tissues.<xref rid="iub2356-bib-0129" ref-type="ref">
<sup>129</sup>
</xref> The suppression of antiviral type I interferons is one of the marked characteristics of SARS&#x02010;CoV infection as well as other group II coronaviruses including mouse hepatitis virus.<xref rid="iub2356-bib-0130" ref-type="ref">
<sup>130</sup>
</xref> It has been shown that the formation of type I interferons is impaired in host cells infected with SARS&#x02010;CoV, but pretreatment of cells with IFN suppresses the growth of SARS&#x02010;CoV.<xref rid="iub2356-bib-0131" ref-type="ref">
<sup>131</sup>
</xref>, <xref rid="iub2356-bib-0132" ref-type="ref">
<sup>132</sup>
</xref> This shows that these viruses have developed mechanisms to overcome IFN responses in infected cells. Type I interferons are rarely found in acute SARS patients, and SARS&#x02010;CoV is sensitive to Pegylated IFN&#x02010;&#x003b1;, as shown in in vivo murine models.<xref rid="iub2356-bib-0133" ref-type="ref">
<sup>133</sup>
</xref> Studies indicated that type I interferon suppression in SARS&#x02010;CoV&#x02010;infected hosts is mediated by the inactivation of the IRF&#x02010;3 (interferon regulatory factor 3) protein, a transcriptional factor that controls the transcription of interferons.<xref rid="iub2356-bib-0132" ref-type="ref">
<sup>132</sup>
</xref> Also, other SARS&#x02010;CoV accessory proteins act as powerful interferon antagonists through various strategies.<xref rid="iub2356-bib-0129" ref-type="ref">
<sup>129</sup>
</xref> For instance, N proteins inhibit the expression of interferons, whereas open&#x02010;reading frame 3b and 6 proteins oppress the signaling pathway and expression of interferons.<xref rid="iub2356-bib-0129" ref-type="ref">
<sup>129</sup>
</xref> Also, open&#x02010;reading frame 6 proteins can halt the translocation of signal transducer and activator of transcription 1 (STAT1). The open&#x02010;reading frame 3b protein is a shuttling protein, impeding the stimulation of type I interferon, which is triggered by retinoic acid&#x02010;inducible gene 1 (RIG&#x02010;I) and mitochondrial antiviral&#x02010;signaling (MAVS) protein.<xref rid="iub2356-bib-0134" ref-type="ref">
<sup>134</sup>
</xref> Additionally, M proteins suppress the production of type I interferon by inhibiting the generation of the TNF Receptor Associated Factor 3 (TRAF3)&#x02013;TRAF Family Member Associated NFKB Activator (TANK) &#x02013; TANK binding kinase 1 (TBK1)/I&#x003ba;B kinase &#x003b5; (IKK&#x003b5;) complex.<xref rid="iub2356-bib-0134" ref-type="ref">
<sup>134</sup>
</xref> Besides, SARS&#x02010;CoV NSP1 proteins are able to halt the expression of IFN&#x02010;&#x003b2; in host cells by promoting the degradation of the host mRNA and the suppression of the translation process.<xref rid="iub2356-bib-0135" ref-type="ref">
<sup>135</sup>
</xref> A polyprotein complex of SARS&#x02010;CoV named papain&#x02010;like protease is able to inhibit the phosphorylation and nuclear translocation of IRF&#x02010;3, resulting in disrupting the activation of type I IFN response via either Toll&#x02010;like receptor 3 (TLR&#x02010;3) or RIG&#x02010;1/melanoma differentiation&#x02010;associated gene 5 (MDA5) complex.<xref rid="iub2356-bib-0136" ref-type="ref">
<sup>136</sup>
</xref> Also, infected cells with SARS&#x02010;CoV can stimulate the expression of protein kinase R (PKR) and PKR&#x02010;like endoplasmic reticulum kinase (PERK).<xref rid="iub2356-bib-0137" ref-type="ref">
<sup>137</sup>
</xref>
</p></sec><sec id="iub2356-sec-0005"><label>1.4</label><title>Bacterial co&#x02010;infection with coronaviruses and <styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19</title><p>Although numerous studies performed on viral and bacterial co&#x02010;infections, little information exists about human coronaviruses. In addition to seasonal influenza, it has been reported corona pathogens of pneumonia include coronavirus 229E, NL63, OC43, SARS, MERS, and SARS&#x02010;CoV&#x02010;2. These viruses can cause co&#x02010;infection in the setting of community&#x02010;acquired bacterial pneumonia.<xref rid="iub2356-bib-0138" ref-type="ref">
<sup>138</sup>
</xref>, <xref rid="iub2356-bib-0139" ref-type="ref">
<sup>139</sup>
</xref>, <xref rid="iub2356-bib-0140" ref-type="ref">
<sup>140</sup>
</xref>, <xref rid="iub2356-bib-0141" ref-type="ref">
<sup>141</sup>
</xref> Human coronavirus NL63 (HCoV&#x02010;NL63) has been recently discovered as a human respiratory pathogen with a high worldwide prevalence.<xref rid="iub2356-bib-0142" ref-type="ref">
<sup>142</sup>
</xref>, <xref rid="iub2356-bib-0143" ref-type="ref">
<sup>143</sup>
</xref> Arguably, HCoV&#x02010;NL63 is among the most clinically significant human coronaviruses and associated with upper and lower respiratory tract infections, frequently occurring in the winter and presenting more severe symptoms in children, the elderly, and immunocompromised patients.<xref rid="iub2356-bib-0142" ref-type="ref">
<sup>142</sup>
</xref>, <xref rid="iub2356-bib-0143" ref-type="ref">
<sup>143</sup>
</xref>, <xref rid="iub2356-bib-0144" ref-type="ref">
<sup>144</sup>
</xref> In a study conducted by Golda et al.,<xref rid="iub2356-bib-0143" ref-type="ref">
<sup>143</sup>
</xref> they evaluated the impact of HCoV&#x02010;NL63 on bacterial adherence causing respiratory tract diseases. HCoV&#x02010;NL63 infection has been shown to enhance the adherence of <italic>S. pneumoniae</italic> to cells infected with the virus.<xref rid="iub2356-bib-0143" ref-type="ref">
<sup>143</sup>
</xref> In one study, Zahariadis et al.<xref rid="iub2356-bib-0072" ref-type="ref">
<sup>72</sup>
</xref> showed the coinfection of SARS patients with other pulmonary pathogens. They found that 30 and 9% of cases with SARS were co&#x02010;infected with <italic>C. pneumoniae</italic> or <italic>M. pneumonia</italic>, respectively. Additionally, Alfaraj et al.<xref rid="iub2356-bib-0075" ref-type="ref">
<sup>75</sup>
</xref> reported the coinfection of MERS&#x02010;CoV with tuberculosis (TB) in two cases. In a study carried out by Wang et al.,<xref rid="iub2356-bib-0145" ref-type="ref">
<sup>145</sup>
</xref> they reported seven cases of SARS&#x02010;related deaths who developed a secondary bacterial infection.</p><p>The COVID&#x02010;19 pandemic caused a large number of immunocompromised individuals to be hospitalized and some reports indicated that some COVID&#x02010;19 patients were diagnosed with secondary infections.<xref rid="iub2356-bib-0030" ref-type="ref">
<sup>30</sup>
</xref>, <xref rid="iub2356-bib-0031" ref-type="ref">
<sup>31</sup>
</xref>, <xref rid="iub2356-bib-0032" ref-type="ref">
<sup>32</sup>
</xref> The specific source and nature of these infections have not yet been fully investigated; however, there is evidence indicating that multidrug&#x02010;resistant bacteria are among those microbes responsible for the development of these secondary infections. In one study, five cases (5.1%) with bacterial co&#x02010;infections including <italic>Acinetobacter baumannii</italic> and <italic>Klebsiella pneumoniae</italic> were found among 99 patients,<xref rid="iub2356-bib-0146" ref-type="ref">
<sup>146</sup>
</xref> while in another study, four cases (9.8%) with secondary bacterial infections were reported among 41 patients.<xref rid="iub2356-bib-0147" ref-type="ref">
<sup>147</sup>
</xref> In a study performed by Zhang et al.,<xref rid="iub2356-bib-0148" ref-type="ref">
<sup>148</sup>
</xref> 221 patients with SARS&#x02010;CoV&#x02010;2 pneumonia were admitted to Zhongnan Hospital, Wuhan, China. Among them, 25.8% (57/221) patients were afflicted with co&#x02010;infections, and among these patients with co&#x02010;infections, 29.8% (17/57) were co&#x02010;infected with bacteria. In a study conducted by Blasco et al.,<xref rid="iub2356-bib-0149" ref-type="ref">
<sup>149</sup>
</xref> they detected one patient who was positive for <italic>M. pneumoniae</italic> coinfection among patients with COVID&#x02010;19 pneumonia. Also, Claire et al.<xref rid="iub2356-bib-0150" ref-type="ref">
<sup>150</sup>
</xref> reported a fatal case of necrotizing pneumonia induced by Panton&#x02010;Valentine leukocidin&#x02013;secreting <italic>S. aureus</italic> in a patient who was affected by COVID&#x02010;19.</p><p>Some patients infected with SARS&#x02010;CoV&#x02010;2 showed the increased levels of biomarkers and inflammatory cytokines related to co&#x02010;infection by bacteria, caused by dysregulation in the immune system.<xref rid="iub2356-bib-0033" ref-type="ref">
<sup>33</sup>
</xref> The management of the severe form of SARS&#x02010;CoV&#x02010;2 is similar to most viral pneumonia&#x02010;causing respiratory failure. In a study carried out by Bordi et al.,<xref rid="iub2356-bib-0151" ref-type="ref">
<sup>151</sup>
</xref> they detected <italic>M. pneumoniae</italic> in five patients (4.0%), while only one patient was infected with <italic>L. pneumophila</italic> and <italic>S. pneumoniae</italic> (0.8%), and mixed infections were also observed in a small number of cases. They found the importance of using a broad&#x02010;spectrum molecular diagnostic panel for rapid detection of the most common respiratory pathogens to improve evaluation and clinical management of patients with a respiratory syndrome consistent with COVID&#x02010;19.<xref rid="iub2356-bib-0151" ref-type="ref">
<sup>151</sup>
</xref> A list of bacterial co&#x02010;infection with COVID&#x02010;19 is depicted in Table <xref rid="iub2356-tbl-0003" ref-type="table">3</xref>.</p><table-wrap id="iub2356-tbl-0003" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 3</label><caption><p>List of bacterial co&#x02010;infection with COVID&#x02010;19</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Bacterium</th><th align="left" valign="bottom" rowspan="1" colspan="1">Infection</th><th align="left" valign="bottom" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Staphylococcus aureus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Necrotizing pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0152" ref-type="ref">152</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Mycoplasma pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Exacerbate clinical symptoms, increase morbidity and prolonged intensive care unit stay</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0153" ref-type="ref">153</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Legionella pneumophila</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0154" ref-type="ref">154</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<p>
<italic>Enterobacter cloacae</italic>
</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0155" ref-type="ref">155</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Acinetobacter baumannii</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0146" ref-type="ref">146</xref>, <xref rid="iub2356-bib-0155" ref-type="ref">155</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Klebsiella pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0146" ref-type="ref">146</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Mycoplasma pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Interstitial pneumonia</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0149" ref-type="ref">149</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Mycoplasma pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0151" ref-type="ref">151</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Legionella pneumophila</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0151" ref-type="ref">151</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Streptococcus pneumoniae</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0151" ref-type="ref">151</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Prevotella</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0156" ref-type="ref">156</xref>, <xref rid="iub2356-bib-0157" ref-type="ref">157</xref>, <xref rid="iub2356-bib-0158" ref-type="ref">158</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Haemophilus</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0158" ref-type="ref">158</xref>, <xref rid="iub2356-bib-0159" ref-type="ref">159</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Lautropia</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0159" ref-type="ref">159</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<italic>Cutibacterium</italic>
</td><td align="left" valign="top" rowspan="1" colspan="1">Not reported</td><td align="left" valign="top" rowspan="1" colspan="1">
<xref rid="iub2356-bib-0159" ref-type="ref">159</xref>
</td></tr></tbody></table></table-wrap><p>One reason for this bacterial co&#x02010;infection is due to many hospital&#x02010;associated bacteria being adapted to develop an infection in individuals with a weakened immune system. It has been noted that the SARS&#x02010;CoV&#x02010;2 infection can damage the cells and the lung infrastructure.<xref rid="iub2356-bib-0160" ref-type="ref">
<sup>160</sup>
</xref> Subsequently, the changed condition enables bacteria to increase adherence and invasion (Figure <xref rid="iub2356-fig-0001" ref-type="fig">1</xref>). It has been found that the mortality rate of viral pandemics is heavily impacted by secondary bacterial infections with myriad numbers of people in the 1918 influenza pandemic as well as the 2009 pandemic, who died from secondary bacterial infections rather than the virus alone.<xref rid="iub2356-bib-0026" ref-type="ref">
<sup>26</sup>
</xref>, <xref rid="iub2356-bib-0027" ref-type="ref">
<sup>27</sup>
</xref>, <xref rid="iub2356-bib-0161" ref-type="ref">
<sup>161</sup>
</xref>
</p><fig fig-type="FIGURE" xml:lang="en" id="iub2356-fig-0001" orientation="portrait" position="float"><label>FIGURE 1</label><caption><p>Postulated schematic of bacterial coinfection with SARS&#x02010;CoV&#x02010;2 infection. It has been proposed when SARS&#x02010; CoV&#x02010;2 infects lung cells can damage the cells and the lung infrastructure.<xref rid="iub2356-bib-0160" ref-type="ref">
<sup>160</sup>
</xref> This situation attracts neutrophil and macrophages to the site of infection and promoting the inflammation.<xref rid="iub2356-bib-0160" ref-type="ref">
<sup>160</sup>
</xref> Finally, the changed situation and epithelial damage can cause bacteria to adhere to and invasion of the cells and proliferation. MQ, macrophage; SARS&#x02010;CoV&#x02010;2, severe acute respiratory syndrome coronavirus 2</p></caption><graphic id="nlm-graphic-1" xlink:href="IUB-9999-na-g001"/></fig><p>Despite the proven significance of co&#x02010;infections in the severity of respiratory diseases, these kinds of infections during large outbreaks of respiratory infections are underdetermined.<xref rid="iub2356-bib-0162" ref-type="ref">
<sup>162</sup>
</xref> For the precise diagnosis and evaluation of co&#x02010;infections during the COVID&#x02010;19 pandemic, samples must be taken longitudinally throughout the disease course via techniques independent of the culture for identifying mixed infections such as whole&#x02010;genome metagenomics (WGMs).<xref rid="iub2356-bib-0162" ref-type="ref">
<sup>162</sup>
</xref> Such works offer valuable monitoring findings on co&#x02010;infection pathogens and drug&#x02010;resistance infections resulting in improved antibiotic prescribing options.<xref rid="iub2356-bib-0162" ref-type="ref">
<sup>162</sup>
</xref> Zhou et al.<xref rid="iub2356-bib-0163" ref-type="ref">
<sup>163</sup>
</xref> found that in the current COVID&#x02010;19 pandemic, 50% of patients who died from Covid&#x02010;19 had bacterial co&#x02010;infections. Correspondingly, Chen et al.<xref rid="iub2356-bib-0146" ref-type="ref">
<sup>146</sup>
</xref> have reported fungal and bacterial co&#x02010;infections in patients with COVID&#x02010;19. COVID&#x02010;19 patients are hospitalized on invasive mechanical ventilation for a long time, leading to higher chances of using a ventilator and hospital&#x02010;acquired infections.<xref rid="iub2356-bib-0162" ref-type="ref">
<sup>162</sup>
</xref> Thus, the rapid diagnosis of a broad range of potential pathogens and antimicrobial resistances for subsequent monitoring of co&#x02010;infection would be crucial. The metagenome of COVID&#x02010;19 patients has shown that Prevotella is a key player in immune response in a Chinese study,<xref rid="iub2356-bib-0156" ref-type="ref">
<sup>156</sup>
</xref> while other opportunistic pathogens were found in a study conducted in the USA.<xref rid="iub2356-bib-0157" ref-type="ref">
<sup>157</sup>
</xref>, <xref rid="iub2356-bib-0158" ref-type="ref">
<sup>158</sup>
</xref>, <xref rid="iub2356-bib-0159" ref-type="ref">
<sup>159</sup>
</xref>, <xref rid="iub2356-bib-0164" ref-type="ref">
<sup>164</sup>
</xref> There is a wide range of bacterial pathogens including Haemophilus, Lautropia, Prevotella have been detected as co&#x02010;infection in Brazil, China, and the USA.<xref rid="iub2356-bib-0157" ref-type="ref">
<sup>157</sup>
</xref>, <xref rid="iub2356-bib-0158" ref-type="ref">
<sup>158</sup>
</xref>, <xref rid="iub2356-bib-0159" ref-type="ref">
<sup>159</sup>
</xref>, <xref rid="iub2356-bib-0164" ref-type="ref">
<sup>164</sup>
</xref>
</p><p>However, a further concern with the rapid expansion of critical care capacity to manage SARS&#x02010;CoV&#x02010;2 can potentially increase the rate of nosocomial infection within the hospital environment.<xref rid="iub2356-bib-0165" ref-type="ref">
<sup>165</sup>
</xref> To date, although the role of viral or bacterial co&#x02010;infection in SARS&#x02010;CoV&#x02010;2 remains elusive, only a few SARS&#x02010;CoV&#x02010;2 patients worldwide have had documented evidence of co&#x02010;infection; however, there is still a concern on this issue as many reports claim that a significant proportion of COVID&#x02010;19 patients developed bacterial co&#x02010;infections.</p></sec><sec id="iub2356-sec-0006"><label>1.5</label><title>The era of post&#x02010;<styled-content style="fixed-case" toggle="no">COVID</styled-content>&#x02010;19 and antimicrobial resistance bacteria</title><p>It has been noted during the current pandemic, the antibiotic administration has been frequently used for COVID&#x02010;19 patients who were admitted to the intensive care unit.<xref rid="iub2356-bib-0165" ref-type="ref">
<sup>165</sup>
</xref> While scientists attempt to understand and control the COVID&#x02010;19 pandemic, it would be also critical to prepare for the effect of the current and future viral pandemics on secondary bacterial infections, resulting in antimicrobial resistance in the near future. In combination with using an antimalarial drug, hydroxyl&#x02010;chloroquine, azithromycin has become a popular therapeutic option for COVID&#x02010;19 patients. Reports demonstrated that a combination of hydroxyl&#x02010;chloroquine and azithromycin was effective for a large proportion of Covid&#x02010;19 patients.<xref rid="iub2356-bib-0166" ref-type="ref">
<sup>166</sup>
</xref>, <xref rid="iub2356-bib-0167" ref-type="ref">
<sup>167</sup>
</xref> It is hard to estimate how often this combination is prescribed, but such a rate would be high enough to cause a shortage of azithromycin. However, 30&#x02013;40% of common types of bacterial agents are already resistant to azithromycin, and overuse could render this or other antibiotics even less effective.<xref rid="iub2356-bib-0168" ref-type="ref">
<sup>168</sup>
</xref> The findings could help experts' advice on using the antibiotics in COVID&#x02010;19 patients and help them to better understand the spread of co&#x02010;infections in hospitals and the mechanism of bacterial&#x02010;viral coinfection. One factor that involves in the antibiotic resistance in bacterial co&#x02010;infection is the widespread use of antibiotics in COVID&#x02010;19 patients. Emerging data show that more than 90% of COVID&#x02010;19 patients receive antibacterial drugs.<xref rid="iub2356-bib-0169" ref-type="ref">
<sup>169</sup>
</xref>, <xref rid="iub2356-bib-0170" ref-type="ref">
<sup>170</sup>
</xref> This rapid increase in antibiotic administration can cause a strong selective pressure on bacterial pathogens to evolve resistance leading to the increased incidence of drug&#x02010;resistant bacterial infections in the years subsequent to the COVID&#x02010;19 pandemic. It was estimated that 10 million people could die from an antibiotic&#x02010;resistant bacterial infection in the year of 2050,<xref rid="iub2356-bib-0171" ref-type="ref">
<sup>171</sup>
</xref> but such prediction may be altered and shortened because of the devastating impact of the COVID&#x02010;19 pandemic on the usage of antibiotics, so this timeline will almost have to be modified. Nevertheless, concerted efforts must be made to better understand antibiotic administration in COVID&#x02010;19 patients. Antibiotics do not directly act on viral infections but viral respiratory infections often lead to bacterial co&#x02010;infections.<xref rid="iub2356-bib-0030" ref-type="ref">
<sup>30</sup>
</xref>, <xref rid="iub2356-bib-0031" ref-type="ref">
<sup>31</sup>
</xref>, <xref rid="iub2356-bib-0032" ref-type="ref">
<sup>32</sup>
</xref> The current pandemic highlights the necessity for understanding the complex relationship between viral and bacterial infections. Of note, in patients who have treated with high&#x02010;dose antibiotics may have more co&#x02010;infections with drug&#x02010;resistant bacteria.</p><p>Additionally, a recent clinical trial conducted by Hagan et al<xref rid="iub2356-bib-0172" ref-type="ref">
<sup>172</sup>
</xref> demonstrated that the use of broad&#x02010;spectrum antibiotics (which led to depleting gut microbiota) decreased and impaired the immune system's ability to generate antibodies. Also, the current study shows that the use of antibiotics perturbed bile acid metabolism and induced inflammatory responses.<xref rid="iub2356-bib-0173" ref-type="ref">
<sup>173</sup>
</xref> Hence, improved functional therapies, including antibiotics and alternative therapies as well as the prediction of bacterial respiratory infections using vaccines, should be regarded as potential therapeutic approaches. Besides, standard guidelines should also be established for the administration of the antibiotics. In addition to the direct effect on drug&#x02010;resistant bacteria as a result of enhanced antibiotic administration, the transmission of drug&#x02010;resistant bacteria through the medical system should be taken into account. The COVID&#x02010;19 pandemic has highlighted the importance of vaccination, the need for functional antimicrobials, as well as the necessity for supporting research into the understanding and control of co&#x02010;infections. Rapid characterization of co&#x02010;infection is essential in the treatment of the most COVID&#x02010;19 patients, and could help to save lives, and will improve antimicrobial stewardship during the pandemic. Additionally, mixed bacterial&#x02010;viral infections can result in antibiotic treatment failure. These observations show that a better understanding of the underlying mechanisms will enable researchers to design effective preventive and therapeutic options. Several functional suggestions for management and control of bacterial co&#x02010;infection with COVID&#x02010;19 are offered in Table <xref rid="iub2356-tbl-0004" ref-type="table">4</xref>.</p><table-wrap id="iub2356-tbl-0004" xml:lang="en" content-type="TABLE" orientation="portrait" position="float"><label>TABLE 4</label><caption><p>Several functional suggestions for management and control of bacterial co&#x02010;infection with COVID&#x02010;19</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Suggestion</th><th align="left" valign="bottom" rowspan="1" colspan="1">Description</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Using a broad&#x02010;spectrum diagnostic panel</td><td align="left" valign="top" rowspan="1" colspan="1">Improves diagnosis, evaluation, and clinical management of patients with other respiratory viral infection concurrent with COVID&#x02010;19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Developing novel treatment and prevention strategies</td><td align="left" valign="top" rowspan="1" colspan="1">Increases our knowledge about the underlying molecular mechanisms accounting for viral&#x02010;bacterial co&#x02010;infection to promote novel therapeutic and prevention approaches</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<p>Performing antibacterial susceptibility tests and potential therapy</p>
</td><td align="left" valign="top" rowspan="1" colspan="1">Prevents reduced antimicrobial susceptibility and treatment failure due to co&#x02010;infections<xref rid="iub2356-bib-0174" ref-type="ref">
<sup>174</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Considering the biofilm&#x02010;associated bacterial infections</td><td align="left" valign="top" rowspan="1" colspan="1">Facilitates treatment management as biofilm formation on artificial devices has been observed previously, thereby affecting infection outcomes, especially in COVID&#x02010;19 patients under mechanical ventilation<xref rid="iub2356-bib-0175" ref-type="ref">
<sup>175</sup>
</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Classifying mechanisms of pathogen interactions</td><td align="left" valign="top" rowspan="1" colspan="1">Increases the ability of infection control as the extension of chemotherapy&#x02010;resistant pathogens is a severe global obstacle<xref rid="iub2356-bib-0174" ref-type="ref">
<sup>174</sup>
</xref>
</td></tr></tbody></table></table-wrap></sec></sec><sec id="iub2356-sec-0007"><label>2</label><title>CONCLUSION</title><p>Respiratory viruses such as SARS&#x02010;CoV&#x02010;2 are well&#x02010;characterized to cause severe disorders and pneumonia, particularly in individuals with serious medical comorbidities and aged populations. Additionally, respiratory virus infection could usually lead to enhanced susceptibility to secondary bacterial infections. However, the mechanisms responsible for bacterial&#x02010;SARS&#x02010;CoV&#x02010;2 co&#x02010;infection require further study. It has been noted that an elicited adaptive immune reaction toward viral infection fails the reaction of the host innate immunity against bacterial infection. This situation can explain why bacterial co&#x02010;infections occur when the virus starts to be eradicated from the lungs of patients with COVID&#x02010;19. This is accompanied by a shift in phagocytic activity of lung cells that mediate basal levels of innate protection via phagocytosis and pro&#x02010;inflammatory cytokines formation to cells better attuned to antigen presentation and stimulation of adaptive immune reactions. Additionally, recently it has been found the microbiome diversity shapes our immune system. In line with this, the depletion of the gut microbiome hinders the immune system's ability to create a humoral response against viruses like the flu virus. However, this novel paradigm ultimately allows the development of new immune intervention approaches for the prevention and management of viral&#x02010;bacterial co&#x02010;infections in COVID&#x02010;19 patients. The COVID&#x02010;19 pandemic reinforces the importance of preventative measures such as vaccination and antimicrobial treatments in maintaining human health.</p></sec><sec sec-type="COI-statement" id="iub2356-sec-0008"><title>CONFLICT OF INTEREST</title><p>The authors declare no conflicts of interest.</p></sec></body><back><ref-list id="iub2356-bibl-0001" content-type="cited-references"><title>REFERENCES</title><ref id="iub2356-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="iub2356-cit-0001">
<string-name>
<surname>Wang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Horby</surname>
<given-names>PW</given-names>
</string-name>, <string-name>
<surname>Hayden</surname>
<given-names>FG</given-names>
</string-name>, <string-name>
<surname>Gao</surname>
<given-names>GF</given-names>
</string-name>. <article-title>A novel coronavirus outbreak of global health concern</article-title>. <source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>470</fpage>&#x02013;<lpage>473</lpage>.<pub-id pub-id-type="pmid">31986257</pub-id></mixed-citation></ref><ref id="iub2356-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="iub2356-cit-0002">
<collab collab-type="authors">Organization T.W.H</collab>
. Coronavirus disease (COVID&#x02010;19) pandemic. <year>2020</year>
<ext-link ext-link-type="uri" xlink:href="https://www.who.int/emergencies/diseases/novel%2010coronavirus%20102019">https://www.who.int/emergencies/diseases/novel-coronavirus-2019</ext-link>.</mixed-citation></ref><ref id="iub2356-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="iub2356-cit-0003">
<string-name>
<surname>Zimmermann</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Curtis</surname>
<given-names>N</given-names>
</string-name>. <article-title>Coronavirus infections in children including COVID&#x02010;19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>. <year>2020</year>;<volume>39</volume>:<fpage>355</fpage>.<pub-id pub-id-type="pmid">32310621</pub-id></mixed-citation></ref><ref id="iub2356-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="iub2356-cit-0004">
<string-name>
<surname>McArdle</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Turkova</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Cunnington</surname>
<given-names>AJ</given-names>
</string-name>. <article-title>When do co&#x02010;infections matter?</article-title>
<source xml:lang="en">Curr Opin Infect Dis</source>. <year>2018</year>;<volume>31</volume>:<fpage>209</fpage>.<pub-id pub-id-type="pmid">29698255</pub-id></mixed-citation></ref><ref id="iub2356-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="iub2356-cit-0005">
<string-name>
<surname>Paget</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Trottein</surname>
<given-names>F</given-names>
</string-name>. <article-title>Mechanisms of bacterial superinfection post&#x02010;influenza: A role for unconventional T cells</article-title>. <source xml:lang="en">Front Immunol</source>. <year>2019</year>;<volume>10</volume>:<fpage>336</fpage>&#x02013;<lpage>336</lpage>.<pub-id pub-id-type="pmid">30881357</pub-id></mixed-citation></ref><ref id="iub2356-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="iub2356-cit-0006">
<string-name>
<surname>Beadling</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Slifka</surname>
<given-names>MK</given-names>
</string-name>. <article-title>How do viral infections predispose patients to bacterial infections?</article-title>
<source xml:lang="en">Curr Opin Infect Dis</source>. <year>2004</year>;<volume>17</volume>:<fpage>185</fpage>&#x02013;<lpage>191</lpage>.<pub-id pub-id-type="pmid">15166819</pub-id></mixed-citation></ref><ref id="iub2356-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="iub2356-cit-0007">
<string-name>
<surname>Metzger</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>K</given-names>
</string-name>. <article-title>Immune dysfunction and bacterial coinfections following influenza</article-title>. <source xml:lang="en">J Immunol (Baltimore, MD: 1950)</source>. <year>2013</year>;<volume>191</volume>:<fpage>2047</fpage>&#x02013;<lpage>2052</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="iub2356-cit-0008">
<string-name>
<surname>Jia</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Xie</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Mechanisms of severe mortality&#x02010;associated bacterial co&#x02010;infections following influenza virus infection</article-title>. <source xml:lang="en">Front Cell Infect Microbiol</source>. <year>2017</year>;<volume>7</volume>:<fpage>338</fpage>.<pub-id pub-id-type="pmid">28824877</pub-id></mixed-citation></ref><ref id="iub2356-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="iub2356-cit-0009">
<string-name>
<surname>Katsurada</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Aoshima</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Yaegashi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ishifuji</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>The impact of virus infections on pneumonia mortality is complex in adults: A prospective multicentre observational study</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2017</year>;<volume>17</volume>:<elocation-id>755</elocation-id>.<pub-id pub-id-type="pmid">29212450</pub-id></mixed-citation></ref><ref id="iub2356-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="iub2356-cit-0010">
<string-name>
<surname>Quah</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Jiang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Siau</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>TY</given-names>
</string-name>. <article-title>Impact of microbial Aetiology on mortality in severe community&#x02010;acquired pneumonia</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2018</year>;<volume>18</volume>:<elocation-id>451</elocation-id>.<pub-id pub-id-type="pmid">30180811</pub-id></mixed-citation></ref><ref id="iub2356-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="iub2356-cit-0011">
<string-name>
<surname>Smith</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Secondary bacterial infections in influenza virus infection pathogenesis</article-title>. <source xml:lang="en">Curr Top Microbiol Immunol</source>. <year>2014</year>;<volume>385</volume>:<fpage>327</fpage>&#x02013;<lpage>356</lpage>.<pub-id pub-id-type="pmid">25027822</pub-id></mixed-citation></ref><ref id="iub2356-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="iub2356-cit-0012">
<string-name>
<surname>Abbasi</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pendergrass</surname>
<given-names>LB</given-names>
</string-name>, <string-name>
<surname>Leggiadro</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Influenza complicated by <italic>Moraxella catarrhalis</italic> bacteremia</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>. <year>1994</year>;<volume>13</volume>:<fpage>937</fpage>&#x02013;<lpage>938</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="iub2356-cit-0013">
<string-name>
<surname>Jacobs</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Viboud</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Tchetgen</surname>
<given-names>ET</given-names>
</string-name>, <string-name>
<surname>Schwartz</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Steiner</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>The association of meningococcal disease with influenza in the United States, 1989&#x02010;2009</article-title>. <source xml:lang="en">PloS One</source>. <year>2014</year>;<volume>9</volume>:<elocation-id>e107486&#x02010;e107486</elocation-id>.<pub-id pub-id-type="pmid">25265409</pub-id></mixed-citation></ref><ref id="iub2356-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="iub2356-cit-0014">
<string-name>
<surname>Mulcahy</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>McLoughlin</surname>
<given-names>RM</given-names>
</string-name>. <article-title>
<italic>Staphylococcus aureus</italic> and influenza A virus: Partners in coinfection</article-title>. <source xml:lang="en">mBio</source>. <year>2016</year>;<volume>7</volume>:<fpage>e02068</fpage>&#x02013;<lpage>e02016</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="iub2356-cit-0015">
<string-name>
<surname>Ochi</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Tauchi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Jogamoto</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Sepsis and pleural empyema caused by <italic>Streptococcus pyogenes</italic> after influenza a virus infection</article-title>. <source xml:lang="en">Case Rep Pediatr</source>. <year>2018</year>;<volume>2018</volume>:<fpage>4509847</fpage>.<pub-id pub-id-type="pmid">30345134</pub-id></mixed-citation></ref><ref id="iub2356-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="iub2356-cit-0016">
<string-name>
<surname>Rowe</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Meliopoulos</surname>
<given-names>VA</given-names>
</string-name>, <string-name>
<surname>Iverson</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Direct interactions with influenza promote bacterial adherence during respiratory infections</article-title>. <source xml:lang="en">Nat Microbiol</source>. <year>2019</year>;<volume>4</volume>:<fpage>1328</fpage>&#x02013;<lpage>1336</lpage>.<pub-id pub-id-type="pmid">31110359</pub-id></mixed-citation></ref><ref id="iub2356-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="iub2356-cit-0017">
<string-name>
<surname>Su</surname>
<given-names>I&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>K&#x02010;L</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>H&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Chuang</surname>
<given-names>H&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>L&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>YJ</given-names>
</string-name>. <article-title>Severe community&#x02010;acquired pneumonia due to <italic>Pseudomonas aeruginosa</italic> coinfection in an influenza a (H1N1) pdm09 patient</article-title>. <source xml:lang="en">J Microbiol Immunol Infect</source>. <year>2019</year>;<volume>52</volume>:<fpage>365</fpage>&#x02013;<lpage>366</lpage>.<pub-id pub-id-type="pmid">29958866</pub-id></mixed-citation></ref><ref id="iub2356-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="iub2356-cit-0018">
<string-name>
<surname>Sun</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Metzger</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Influenza and <italic>Staphylococcus aureus</italic> coinfection: TLR9 at play</article-title>. <source xml:lang="en">Trends Microbiol</source>. <year>2019</year>;<volume>27</volume>:<fpage>383</fpage>&#x02013;<lpage>384</lpage>.<pub-id pub-id-type="pmid">30871857</pub-id></mixed-citation></ref><ref id="iub2356-bib-0019"><label>19</label><mixed-citation publication-type="book" id="iub2356-cit-0019">
<string-name>
<surname>Dasaraju</surname>
<given-names>PV</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>C</given-names>
</string-name>. <chapter-title>Chapter 93: Infections of the respiratory system</chapter-title>
<source xml:lang="en">Medical microbiology</source>. <edition designator="4">4th ed.</edition>
<publisher-loc>Galveston</publisher-loc>: <publisher-name>University of Texas Medical Branch at Galveston</publisher-name>, <year>1996</year>.</mixed-citation></ref><ref id="iub2356-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="iub2356-cit-0020">
<string-name>
<surname>MacIntyre</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Bui</surname>
<given-names>CM</given-names>
</string-name>. <article-title>Pandemics, public health emergencies and antimicrobial resistance &#x02010; putting the threat in an epidemiologic and risk analysis context</article-title>. <source xml:lang="en">Arch Public Health</source>. <year>2017</year>;<volume>75</volume>:<fpage>54</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">28924475</pub-id></mixed-citation></ref><ref id="iub2356-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="iub2356-cit-0021">
<string-name>
<surname>Bengoechea</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Bamford</surname>
<given-names>CG</given-names>
</string-name>. <article-title>SARS&#x02010;CoV&#x02010;2, bacterial co&#x02010;infections, and AMR: The deadly trio in COVID&#x02010;19?</article-title>
<source xml:lang="en">EMBO Mol Med</source>. <year>2020</year>;<volume>12</volume>(<issue>7</issue>):<elocation-id>e12560</elocation-id>.<pub-id pub-id-type="pmid">32453917</pub-id></mixed-citation></ref><ref id="iub2356-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="iub2356-cit-0022">
<string-name>
<surname>Hendaus</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Jomha</surname>
<given-names>FA</given-names>
</string-name>. <article-title>Covid&#x02010;19 induced superimposed bacterial infection</article-title>. <source xml:lang="en">J Biomol Struct Dyn</source>. <year>2020</year>;<fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="iub2356-cit-0023">
<string-name>
<surname>Rawson</surname>
<given-names>TM</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Bacterial and fungal co&#x02010;infection in individuals with coronavirus: A rapid review to support COVID&#x02010;19 antimicrobial prescribing</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="iub2356-cit-0024">
<string-name>
<surname>Cauley</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Vella</surname>
<given-names>AT</given-names>
</string-name>. <article-title>Why is coinfection with influenza virus and bacteria so difficult to control</article-title>. <source xml:lang="en">Discov Med</source>. <year>2015</year>;<volume>19</volume>:<fpage>33</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">25636959</pub-id></mixed-citation></ref><ref id="iub2356-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="iub2356-cit-0025">
<string-name>
<surname>Sun</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Yajjala</surname>
<given-names>VK.</given-names>
</string-name>
<article-title>Nox2&#x02010;derived oxidative stress results in inefficacy of antibiotics against post&#x02010;influenza <italic>S. aureus</italic> pneumonia</article-title>. <source xml:lang="en">J Exp Med.</source>
<year>2016</year>;<volume>213</volume>:<fpage>1851</fpage>&#x02013;<lpage>1864</lpage>.<pub-id pub-id-type="pmid">27526712</pub-id></mixed-citation></ref><ref id="iub2356-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="iub2356-cit-0026">
<article-title>A tool for the potential fall 2009 wave of pandemic H1N1 to guide public health decision&#x02010;making: An overview of the Public Health Agency of Canada's planning considerations, September 2009</article-title>. <source xml:lang="en">Can Commun Dis Rep</source>. <year>2010</year>;<volume>36</volume>:<fpage>1</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0027"><label>27</label><mixed-citation publication-type="journal" id="iub2356-cit-0027">
<string-name>
<surname>Morris</surname>
<given-names>DE</given-names>
</string-name>, <string-name>
<surname>Cleary</surname>
<given-names>DW</given-names>
</string-name>, <string-name>
<surname>Clarke</surname>
<given-names>SC</given-names>
</string-name>. <article-title>Secondary bacterial infections associated with influenza pandemics</article-title>. <source xml:lang="en">Front Microbiol</source>. <year>2017</year>;<volume>8</volume>:<fpage>1041</fpage>.<pub-id pub-id-type="pmid">28690590</pub-id></mixed-citation></ref><ref id="iub2356-bib-0028"><label>28</label><mixed-citation publication-type="book" id="iub2356-cit-0028">
<string-name>
<surname>Smith</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sweet</surname>
<given-names>C</given-names>
</string-name>. <chapter-title>Cooperation between viral and bacterial pathogens in causing human respiratory disease</chapter-title>
<source xml:lang="en">Polymicrobial Diseases</source>. <publisher-name>ASM Press</publisher-name>, <year>2002</year>.</mixed-citation></ref><ref id="iub2356-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="iub2356-cit-0029">
<string-name>
<surname>Almand</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>MD</given-names>
</string-name>, <string-name>
<surname>Jaykus</surname>
<given-names>L&#x02010;A</given-names>
</string-name>. <article-title>Virus&#x02010;bacteria interactions: An emerging topic in human infection</article-title>. <source xml:lang="en">Viruses</source>. <year>2017</year>;<volume>9</volume>:<fpage>58</fpage>.</mixed-citation></ref><ref id="iub2356-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="iub2356-cit-0030">
<string-name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Smulian</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Lednicky</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Jamieson</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Coronavirus disease 2019 (COVID&#x02010;19) and pregnancy: What obstetricians need to know</article-title>. <source xml:lang="en">Am J Obstet Gynecol</source>. <year>2020</year>;<volume>222</volume>(<issue>5</issue>):<fpage>415</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">32105680</pub-id></mixed-citation></ref><ref id="iub2356-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="iub2356-cit-0031">
<string-name>
<surname>Ritchie</surname>
<given-names>AI</given-names>
</string-name>, <string-name>
<surname>Singanayagam</surname>
<given-names>A</given-names>
</string-name>. <article-title>Immunosuppression for hyperinflammation in COVID&#x02010;19: A double&#x02010;edged sword?</article-title>
<source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>1111</fpage>.</mixed-citation></ref><ref id="iub2356-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="iub2356-cit-0032">
<string-name>
<surname>Tetro</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Is COVID&#x02010;19 receiving ADE from other coronaviruses?</article-title>
<source xml:lang="en">Microbes Infect</source>. <year>2020</year>;<volume>22</volume>:<fpage>72</fpage>&#x02013;<lpage>73</lpage>.<pub-id pub-id-type="pmid">32092539</pub-id></mixed-citation></ref><ref id="iub2356-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="iub2356-cit-0033">
<string-name>
<surname>Zhang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Tan</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Treatment with convalescent plasma for critically ill patients with SARS&#x02010;CoV&#x02010;2 infection</article-title>. <source xml:lang="en">Chest</source>. <year>2020</year>;<volume>158</volume>(<issue>1</issue>):<fpage>e9</fpage>&#x02013;<lpage>e13</lpage>.<pub-id pub-id-type="pmid">32243945</pub-id></mixed-citation></ref><ref id="iub2356-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="iub2356-cit-0034">
<string-name>
<surname>Crotty</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Meyers</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Hampton</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Epidemiology, co&#x02010;infections, and outcomes of viral pneumonia in adults: An observational cohort study</article-title>. <source xml:lang="en">Medicine (Baltimore)</source>. <year>2015</year>;<volume>94</volume>:<fpage>e2332</fpage>&#x02013;<lpage>e2332</lpage>.<pub-id pub-id-type="pmid">26683973</pub-id></mixed-citation></ref><ref id="iub2356-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="iub2356-cit-0035">
<string-name>
<surname>Morens</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Taubenberger</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Fauci</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2008</year>;<volume>198</volume>:<fpage>962</fpage>&#x02013;<lpage>970</lpage>.<pub-id pub-id-type="pmid">18710327</pub-id></mixed-citation></ref><ref id="iub2356-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="iub2356-cit-0036">
<string-name>
<surname>Investigators</surname>
<given-names>AI</given-names>
</string-name>. <article-title>Critical care services and 2009 H1N1 influenza in Australia and New Zealand</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2009</year>;<volume>361</volume>:<fpage>1925</fpage>&#x02013;<lpage>1934</lpage>.<pub-id pub-id-type="pmid">19815860</pub-id></mixed-citation></ref><ref id="iub2356-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="iub2356-cit-0037">
<string-name>
<surname>Cill&#x000f3;niz</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ewig</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Men&#x000e9;ndez</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Bacterial co&#x02010;infection with H1N1 infection in patients admitted with community acquired pneumonia</article-title>. <source xml:lang="en">J Infect</source>. <year>2012</year>;<volume>65</volume>:<fpage>223</fpage>&#x02013;<lpage>230</lpage>.<pub-id pub-id-type="pmid">22543245</pub-id></mixed-citation></ref><ref id="iub2356-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="iub2356-cit-0038">
<string-name>
<surname>Rice</surname>
<given-names>TW</given-names>
</string-name>, <string-name>
<surname>Rubinson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Uyeki</surname>
<given-names>TM</given-names>
</string-name>, et al. <article-title>Critical illness from 2009 pandemic influenza a (H1N1) virus and bacterial co&#x02010;infection in the United States</article-title>. <source xml:lang="en">Crit Care Med</source>. <year>2012</year>;<volume>40</volume>:<fpage>1487</fpage>.<pub-id pub-id-type="pmid">22511131</pub-id></mixed-citation></ref><ref id="iub2356-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="iub2356-cit-0039">
<string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Bartmess</surname>
<given-names>KC</given-names>
</string-name>. <article-title>Role of neuraminidase in lethal synergism between influenza virus and <italic>Streptococcus pneumoniae</italic>
</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2003</year>;<volume>187</volume>:<fpage>1000</fpage>&#x02013;<lpage>1009</lpage>.<pub-id pub-id-type="pmid">12660947</pub-id></mixed-citation></ref><ref id="iub2356-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="iub2356-cit-0040">
<string-name>
<surname>Peltola</surname>
<given-names>VT</given-names>
</string-name>, <string-name>
<surname>Murti</surname>
<given-names>KG</given-names>
</string-name>, <string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Influenza virus neuraminidase contributes to secondary bacterial pneumonia</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2005</year>;<volume>192</volume>:<fpage>249</fpage>&#x02013;<lpage>257</lpage>.<pub-id pub-id-type="pmid">15962219</pub-id></mixed-citation></ref><ref id="iub2356-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="iub2356-cit-0041">
<string-name>
<surname>Rothberg</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Haessler</surname>
<given-names>SD</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>RB</given-names>
</string-name>. <article-title>Complications of viral influenza</article-title>. <source xml:lang="en">Am J Med</source>. <year>2008</year>;<volume>121</volume>:<fpage>258</fpage>&#x02013;<lpage>264</lpage>.<pub-id pub-id-type="pmid">18374680</pub-id></mixed-citation></ref><ref id="iub2356-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="iub2356-cit-0042">
<string-name>
<surname>Bakaletz</surname>
<given-names>LO</given-names>
</string-name>. <article-title>Viral&#x02010;bacterial co&#x02010;infections in the respiratory tract</article-title>. <source xml:lang="en">Curr Opin Microbiol</source>. <year>2017</year>;<volume>35</volume>:<fpage>30</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">27940028</pub-id></mixed-citation></ref><ref id="iub2356-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="iub2356-cit-0043">
<string-name>
<surname>Korppi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Don</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Valent</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Canciani</surname>
<given-names>M</given-names>
</string-name>. <article-title>The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children</article-title>. <source xml:lang="en">Acta Paediatr</source>. <year>2008</year>;<volume>97</volume>:<fpage>943</fpage>&#x02013;<lpage>947</lpage>.<pub-id pub-id-type="pmid">18422803</pub-id></mixed-citation></ref><ref id="iub2356-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="iub2356-cit-0044">
<string-name>
<surname>Allander</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tammi</surname>
<given-names>MT</given-names>
</string-name>, <string-name>
<surname>Eriksson</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Cloning of a human parvovirus by molecular screening of respiratory tract samples</article-title>. <source xml:lang="en">Proc Natl Acad Sci</source>. <year>2005</year>;<volume>102</volume>:<fpage>12891</fpage>&#x02013;<lpage>12896</lpage>.<pub-id pub-id-type="pmid">16118271</pub-id></mixed-citation></ref><ref id="iub2356-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="iub2356-cit-0045">
<string-name>
<surname>Gatherer</surname>
<given-names>D</given-names>
</string-name>. <article-title>The 2009 H1N1 influenza outbreak in its historical context</article-title>. <source xml:lang="en">J Clin Virol</source>. <year>2009</year>;<volume>45</volume>:<fpage>174</fpage>&#x02013;<lpage>178</lpage>.<pub-id pub-id-type="pmid">19540156</pub-id></mixed-citation></ref><ref id="iub2356-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="iub2356-cit-0046">
<string-name>
<surname>van der Hoek</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ihorst</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Sure</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Burden of disease due to human coronavirus NL63 infections and periodicity of infection</article-title>. <source xml:lang="en">J Clin Virol</source>. <year>2010</year>;<volume>48</volume>:<fpage>104</fpage>&#x02013;<lpage>108</lpage>.<pub-id pub-id-type="pmid">20347384</pub-id></mixed-citation></ref><ref id="iub2356-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="iub2356-cit-0047">
<string-name>
<surname>Abdel&#x02010;Moneim</surname>
<given-names>AS</given-names>
</string-name>. <article-title>Middle East respiratory syndrome coronavirus (MERS&#x02010;CoV): Evidence and speculations</article-title>. <source xml:lang="en">Arch Virol</source>. <year>2014</year>;<volume>159</volume>:<fpage>1575</fpage>&#x02013;<lpage>1584</lpage>.<pub-id pub-id-type="pmid">24515532</pub-id></mixed-citation></ref><ref id="iub2356-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="iub2356-cit-0048">
<string-name>
<surname>El</surname>
<given-names>ZME</given-names>
</string-name>, <string-name>
<surname>J&#x000e4;rhult</surname>
<given-names>JD</given-names>
</string-name>. <article-title>From SARS to COVID&#x02010;19: A previously unknown SARS&#x02010;CoV&#x02010;2 virus of pandemic potential infecting humans&#x02013;call for a one health approach</article-title>. <source xml:lang="en">One Health</source>. <year>2020</year>;<volume>9</volume>:<fpage>100124</fpage>.<pub-id pub-id-type="pmid">32195311</pub-id></mixed-citation></ref><ref id="iub2356-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="iub2356-cit-0049">
<string-name>
<surname>Basarab</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Macrae</surname>
<given-names>MB</given-names>
</string-name>, <string-name>
<surname>Curtis</surname>
<given-names>CM</given-names>
</string-name>. <article-title>Atypical pneumonia</article-title>. <source xml:lang="en">Curr Opin Pulm Med</source>. <year>2014</year>;<volume>20</volume>:<fpage>247</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">24626238</pub-id></mixed-citation></ref><ref id="iub2356-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="iub2356-cit-0050">
<string-name>
<surname>Baroudy</surname>
<given-names>NRE</given-names>
</string-name>, <string-name>
<surname>Refay</surname>
<given-names>ASE</given-names>
</string-name>, <string-name>
<surname>Hamid</surname>
<given-names>TAA</given-names>
</string-name>, et al. <article-title>Respiratory viruses and atypical bacteria co&#x02010;infection in children with acute respiratory infection</article-title>. <source xml:lang="en">Open Access Maced J Med Sci</source>. <year>2018</year>;<volume>6</volume>:<fpage>1588</fpage>&#x02013;<lpage>1593</lpage>.<pub-id pub-id-type="pmid">30337970</pub-id></mixed-citation></ref><ref id="iub2356-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="iub2356-cit-0051">
<string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Insights into the interaction between influenza virus and pneumococcus</article-title>. <source xml:lang="en">Clin Microbiol Rev</source>. <year>2006</year>;<volume>19</volume>:<fpage>571</fpage>&#x02013;<lpage>582</lpage>.<pub-id pub-id-type="pmid">16847087</pub-id></mixed-citation></ref><ref id="iub2356-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="iub2356-cit-0052">
<string-name>
<surname>Iverson</surname>
<given-names>AR</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>McAuley</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Plano</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Influenza virus primes mice for pneumonia from <italic>Staphylococcus aureus</italic>
</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2011</year>;<volume>203</volume>:<fpage>880</fpage>&#x02013;<lpage>888</lpage>.<pub-id pub-id-type="pmid">21278211</pub-id></mixed-citation></ref><ref id="iub2356-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="iub2356-cit-0053">
<string-name>
<surname>Robertson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Caley</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>J</given-names>
</string-name>. <article-title>Importance of <italic>Staphylococcus aureus</italic> in pneumonia in the 1957, epidemic of influenza a</article-title>. <source xml:lang="en">Lancet</source>. <year>1958</year>;<volume>272</volume>:<fpage>233</fpage>&#x02013;<lpage>236</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="iub2356-cit-0054">
<article-title>Severe methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic> community&#x02010;acquired pneumonia associated with influenza&#x02013;Louisiana and Georgia, December 2006&#x02013;January 2007</article-title>. <source xml:lang="en">MMWR Morb Mortal Wkly Rep</source>. <year>2007</year>;<volume>56</volume>:<fpage>325</fpage>&#x02013;<lpage>329</lpage>.<pub-id pub-id-type="pmid">17431376</pub-id></mixed-citation></ref><ref id="iub2356-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="iub2356-cit-0055">
<string-name>
<surname>Finelli</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Fiore</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Dhara</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Influenza&#x02010;associated pediatric mortality in the United States: Increase of <italic>Staphylococcus aureus</italic> coinfection</article-title>. <source xml:lang="en">Pediatrics</source>. <year>2008</year>;<volume>122</volume>:<fpage>805</fpage>&#x02013;<lpage>811</lpage>.<pub-id pub-id-type="pmid">18829805</pub-id></mixed-citation></ref><ref id="iub2356-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="iub2356-cit-0056">
<string-name>
<surname>Reed</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Kallen</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Patton</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>Infection with community&#x02010;onset <italic>Staphylococcus aureus</italic> and influenza virus in hospitalized children</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>. <year>2009</year>;<volume>28</volume>:<fpage>572</fpage>&#x02013;<lpage>576</lpage>.<pub-id pub-id-type="pmid">19478685</pub-id></mixed-citation></ref><ref id="iub2356-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="iub2356-cit-0057">
<string-name>
<surname>Gao</surname>
<given-names>H&#x02010;N</given-names>
</string-name>, <string-name>
<surname>Lu</surname>
<given-names>H&#x02010;Z</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Clinical findings in 111 cases of influenza a (H7N9) virus infection</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>2013</year>;<volume>368</volume>:<fpage>2277</fpage>&#x02013;<lpage>2285</lpage>.<pub-id pub-id-type="pmid">23697469</pub-id></mixed-citation></ref><ref id="iub2356-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="iub2356-cit-0058">
<string-name>
<surname>Palacios</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hornig</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Cisterna</surname>
<given-names>D</given-names>
</string-name>, et al. <article-title>
<italic>Streptococcus pneumoniae</italic> coinfection is correlated with the severity of H1N1 pandemic influenza</article-title>. <source xml:lang="en">PloS One</source>. <year>2009</year>;<volume>4</volume>:<fpage>e8540</fpage>&#x02013;<lpage>e8540</lpage>.<pub-id pub-id-type="pmid">20046873</pub-id></mixed-citation></ref><ref id="iub2356-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="iub2356-cit-0059">
<string-name>
<surname>Wang</surname>
<given-names>X&#x02010;Y</given-names>
</string-name>, <string-name>
<surname>Kilgore</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>KA</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>S&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Influenza and bacterial pathogen coinfections in the 20th century</article-title>. <source xml:lang="en">Interdisc Perspect Infect Dis</source>. <year>2011</year>;<volume>2011</volume>:<elocation-id>146376</elocation-id>.</mixed-citation></ref><ref id="iub2356-bib-0060"><label>60</label><mixed-citation publication-type="journal" id="iub2356-cit-0060">
<string-name>
<surname>Doern</surname>
<given-names>GV</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Pfaller</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Kugler</surname>
<given-names>K</given-names>
</string-name>, <collab collab-type="authors">Group S.P</collab>
. <article-title>
<italic>Haemophilus influenzae</italic> and <italic>Moraxella catarrhalis</italic> from patients with community&#x02010;acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997)</article-title>. <source xml:lang="en">Antimicrob Agents Chemother</source>. <year>1999</year>;<volume>43</volume>:<fpage>385</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">9925540</pub-id></mixed-citation></ref><ref id="iub2356-bib-0061"><label>61</label><mixed-citation publication-type="journal" id="iub2356-cit-0061">
<string-name>
<surname>Simmons</surname>
<given-names>WP</given-names>
</string-name>. <article-title>
<italic>Moraxella catarrhalis</italic> pneumonia and bacteremia in an otherwise healthy child</article-title>. <source xml:lang="en">Clin Pediatr</source>. <year>1999</year>;<volume>38</volume>:<fpage>560</fpage>&#x02013;<lpage>561</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0062"><label>62</label><mixed-citation publication-type="journal" id="iub2356-cit-0062">
<string-name>
<surname>Young</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>LaForce</surname>
<given-names>FM</given-names>
</string-name>, <string-name>
<surname>Head</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Feeley</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Bennett</surname>
<given-names>JV</given-names>
</string-name>. <article-title>A simultaneous outbreak of meningococcal and influenza infections</article-title>. <source xml:lang="en">N Engl J Med</source>. <year>1972</year>;<volume>287</volume>:<fpage>5</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">4623954</pub-id></mixed-citation></ref><ref id="iub2356-bib-0063"><label>63</label><mixed-citation publication-type="journal" id="iub2356-cit-0063">
<string-name>
<surname>Jansen</surname>
<given-names>AGSC</given-names>
</string-name>, <string-name>
<surname>Sanders</surname>
<given-names>EAM</given-names>
</string-name>, <string-name>
<surname>Van Der Ende</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Invasive pneumococcal and meningococcal disease: Association with influenza virus and respiratory syncytial virus activity?</article-title>
<source xml:lang="en">Epidemiol Infect</source>. <year>2008</year>;<volume>136</volume>:<fpage>1448</fpage>&#x02013;<lpage>1454</lpage>.<pub-id pub-id-type="pmid">18211724</pub-id></mixed-citation></ref><ref id="iub2356-bib-0064"><label>64</label><mixed-citation publication-type="journal" id="iub2356-cit-0064">
<string-name>
<surname>Mina</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Burke</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Klugman</surname>
<given-names>K</given-names>
</string-name>. <article-title>Estimating the prevalence of coinfection with influenza virus and the atypical bacteria <italic>Bordetella pertussis</italic>, <italic>Chlamydophila pneumoniae</italic>, and <italic>Mycoplasma pneumoniae</italic>
</article-title>. <source xml:lang="en">Eur J Clin Microbiol Infect Dis</source>. <year>2014</year>;<volume>33</volume>:<fpage>1585</fpage>&#x02013;<lpage>1589</lpage>.<pub-id pub-id-type="pmid">24789653</pub-id></mixed-citation></ref><ref id="iub2356-bib-0065"><label>65</label><mixed-citation publication-type="journal" id="iub2356-cit-0065">
<string-name>
<surname>Wolf</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Greenberg</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Shemer&#x02010;Avni</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Givon&#x02010;Lavi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bar&#x02010;Ziv</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Dagan</surname>
<given-names>R</given-names>
</string-name>. <article-title>Association of human metapneumovirus with radiologically diagnosed community&#x02010;acquired alveolar pneumonia in young children</article-title>. <source xml:lang="en">J Pediatr</source>. <year>2010</year>;<volume>156</volume>:<fpage>115</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">19782998</pub-id></mixed-citation></ref><ref id="iub2356-bib-0066"><label>66</label><mixed-citation publication-type="journal" id="iub2356-cit-0066">
<string-name>
<surname>Van Ewijk</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Wolfs</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Aerts</surname>
<given-names>PC</given-names>
</string-name>, et al. <article-title>RSV mediates <italic>Pseudomonas aeruginosa</italic> binding to cystic fibrosis and normal epithelial cells</article-title>. <source xml:lang="en">Pediatr Res</source>. <year>2007</year>;<volume>61</volume>:<fpage>398</fpage>&#x02013;<lpage>403</lpage>.<pub-id pub-id-type="pmid">17515861</pub-id></mixed-citation></ref><ref id="iub2356-bib-0067"><label>67</label><mixed-citation publication-type="journal" id="iub2356-cit-0067">
<string-name>
<surname>Petersen</surname>
<given-names>NT</given-names>
</string-name>, <string-name>
<surname>H&#x000f8;iby</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Mordhorst</surname>
<given-names>CH</given-names>
</string-name>, <string-name>
<surname>Lind</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Flensborg</surname>
<given-names>EW</given-names>
</string-name>, <string-name>
<surname>BRUUN</surname>
<given-names>B</given-names>
</string-name>. <article-title>Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma&#x02013;possible synergism with <italic>Pseudomonas aeruginosa</italic>
</article-title>. <source xml:lang="en">Acta Paediatr</source>. <year>1981</year>;<volume>70</volume>:<fpage>623</fpage>&#x02013;<lpage>628</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0068"><label>68</label><mixed-citation publication-type="journal" id="iub2356-cit-0068">
<string-name>
<surname>Korppi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Leinonen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>M&#x000e4;kel&#x000e4;</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Launiala</surname>
<given-names>K</given-names>
</string-name>. <article-title>Mixed infection is common in children with respiratory adenovirus infection</article-title>. <source xml:lang="en">Acta Paediatr</source>. <year>1991</year>;<volume>80</volume>:<fpage>413</fpage>&#x02013;<lpage>417</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0069"><label>69</label><mixed-citation publication-type="journal" id="iub2356-cit-0069">
<string-name>
<surname>Korppi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Leinonen</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>M&#x000e4;kel&#x000e4;</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Launiala</surname>
<given-names>K</given-names>
</string-name>. <article-title>Bacterial involvement in parainfluenza virus infection in children</article-title>. <source xml:lang="en">Scand J Infect Dis</source>. <year>1990</year>;<volume>22</volume>:<fpage>307</fpage>&#x02013;<lpage>312</lpage>.<pub-id pub-id-type="pmid">2164707</pub-id></mixed-citation></ref><ref id="iub2356-bib-0070"><label>70</label><mixed-citation publication-type="journal" id="iub2356-cit-0070">
<string-name>
<surname>Tong</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Meng</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>The sialic acid binding activity of human parainfluenza virus 3 and mumps virus glycoproteins enhances the adherence of group B streptococci to HEp&#x02010;2 cells</article-title>. <source xml:lang="en">Front Cell Infect Microbiol</source>. <year>2018</year>;<volume>8</volume>:<fpage>280</fpage>.<pub-id pub-id-type="pmid">30175075</pub-id></mixed-citation></ref><ref id="iub2356-bib-0071"><label>71</label><mixed-citation publication-type="journal" id="iub2356-cit-0071">
<string-name>
<surname>Katiyar</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Agarwal</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Chowdhary</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Incidence of human rhinovirus coinfection with <italic>Staphylococcus aureus</italic> among HIV patients suffering from flu like illness</article-title>. <source xml:lang="en">Int J Pharm Sci Res</source>. <year>2017</year>;<volume>8</volume>:<fpage>4441</fpage>&#x02013;<lpage>4446</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0072"><label>72</label><mixed-citation publication-type="journal" id="iub2356-cit-0072">
<string-name>
<surname>Zahariadis</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Gooley</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Ryall</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Risk of ruling out severe acute respiratory syndrome by ruling in another diagnosis: Variable incidence of atypical bacteria coinfection based on diagnostic assays</article-title>. <source xml:lang="en">Can Respir J</source>. <year>2006</year>;<volume>13</volume>:<fpage>17</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="pmid">16470249</pub-id></mixed-citation></ref><ref id="iub2356-bib-0073"><label>73</label><mixed-citation publication-type="journal" id="iub2356-cit-0073">
<string-name>
<surname>Yap</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Gomersall</surname>
<given-names>CD</given-names>
</string-name>, <string-name>
<surname>Fung</surname>
<given-names>KS</given-names>
</string-name>, et al. <article-title>Increase in methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic> acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2004</year>;<volume>39</volume>:<fpage>511</fpage>&#x02013;<lpage>516</lpage>.<pub-id pub-id-type="pmid">15356814</pub-id></mixed-citation></ref><ref id="iub2356-bib-0074"><label>74</label><mixed-citation publication-type="journal" id="iub2356-cit-0074">
<string-name>
<surname>Bassetti</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Bischoff</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Sherertz</surname>
<given-names>RJ</given-names>
</string-name>. <article-title>Outbreak of methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic> infection associated with an outbreak of severe acute respiratory syndrome</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2005</year>;<volume>40</volume>:<fpage>633</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">15712093</pub-id></mixed-citation></ref><ref id="iub2356-bib-0075"><label>75</label><mixed-citation publication-type="journal" id="iub2356-cit-0075">
<string-name>
<surname>Alfaraj</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Tawfiq</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Altuwaijri</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Memish</surname>
<given-names>ZA</given-names>
</string-name>. <article-title>Middle East respiratory syndrome coronavirus and pulmonary tuberculosis coinfection: Implications for infection control</article-title>. <source xml:lang="en">Intervirology</source>. <year>2017</year>;<volume>60</volume>:<fpage>53</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">28683463</pub-id></mixed-citation></ref><ref id="iub2356-bib-0076"><label>76</label><mixed-citation publication-type="journal" id="iub2356-cit-0076">
<string-name>
<surname>Arabi</surname>
<given-names>YM</given-names>
</string-name>, <string-name>
<surname>Deeb</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Al&#x02010;Hameed</surname>
<given-names>F</given-names>
</string-name>, et al. <article-title>Macrolides in critically ill patients with Middle East respiratory syndrome</article-title>. <source xml:lang="en">Int J Infect Dis</source>. <year>2019</year>;<volume>81</volume>:<fpage>184</fpage>&#x02013;<lpage>190</lpage>.<pub-id pub-id-type="pmid">30690213</pub-id></mixed-citation></ref><ref id="iub2356-bib-0077"><label>77</label><mixed-citation publication-type="journal" id="iub2356-cit-0077">
<string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>The co&#x02010;pathogenesis of influenza viruses with bacteria in the lung</article-title>. <source xml:lang="en">Nat Rev Microbiol</source>. <year>2014</year>;<volume>12</volume>:<fpage>252</fpage>&#x02013;<lpage>262</lpage>.<pub-id pub-id-type="pmid">24590244</pub-id></mixed-citation></ref><ref id="iub2356-bib-0078"><label>78</label><mixed-citation publication-type="journal" id="iub2356-cit-0078">
<string-name>
<surname>Peltola</surname>
<given-names>VT</given-names>
</string-name>, <string-name>
<surname>Boyd</surname>
<given-names>KL</given-names>
</string-name>, <string-name>
<surname>McAuley</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Rehg</surname>
<given-names>JE</given-names>
</string-name>, <string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Bacterial sinusitis and otitis media following influenza virus infection in ferrets</article-title>. <source xml:lang="en">Infect Immun</source>. <year>2006</year>;<volume>74</volume>:<fpage>2562</fpage>&#x02013;<lpage>2567</lpage>.<pub-id pub-id-type="pmid">16622191</pub-id></mixed-citation></ref><ref id="iub2356-bib-0079"><label>79</label><mixed-citation publication-type="journal" id="iub2356-cit-0079">
<string-name>
<surname>Ballinger</surname>
<given-names>MN</given-names>
</string-name>, <string-name>
<surname>Standiford</surname>
<given-names>TJ</given-names>
</string-name>. <article-title>Postinfluenza bacterial pneumonia: Host defenses gone awry</article-title>. <source xml:lang="en">J Interferon Cytokine Res</source>. <year>2010</year>;<volume>30</volume>:<fpage>643</fpage>&#x02013;<lpage>652</lpage>.<pub-id pub-id-type="pmid">20726789</pub-id></mixed-citation></ref><ref id="iub2356-bib-0080"><label>80</label><mixed-citation publication-type="journal" id="iub2356-cit-0080">
<string-name>
<surname>Li</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ren</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Influenza viral neuraminidase primes bacterial coinfection through TGF&#x02010;&#x003b2;&#x02013;mediated expression of host cell receptors</article-title>. <source xml:lang="en">Proc Natl Acad Sci</source>. <year>2015</year>;<volume>112</volume>:<fpage>238</fpage>&#x02013;<lpage>243</lpage>.<pub-id pub-id-type="pmid">25535343</pub-id></mixed-citation></ref><ref id="iub2356-bib-0081"><label>81</label><mixed-citation publication-type="journal" id="iub2356-cit-0081">
<string-name>
<surname>Nakamura</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Davis</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Weiser</surname>
<given-names>JN</given-names>
</string-name>. <article-title>Synergistic stimulation of type I interferons during influenza virus coinfection promotes <italic>Streptococcus pneumoniae</italic> colonization in mice</article-title>. <source xml:lang="en">J Clin Invest</source>. <year>2011</year>;<volume>121</volume>:<fpage>3657</fpage>&#x02013;<lpage>3665</lpage>.<pub-id pub-id-type="pmid">21841308</pub-id></mixed-citation></ref><ref id="iub2356-bib-0082"><label>82</label><mixed-citation publication-type="journal" id="iub2356-cit-0082">
<string-name>
<surname>Smith</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Adler</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Ribeiro</surname>
<given-names>RM</given-names>
</string-name>, et al. <article-title>Kinetics of coinfection with influenza a virus and <italic>Streptococcus pneumoniae</italic>
</article-title>. <source xml:lang="en">PLoS Pathog</source>. <year>2013</year>;<volume>9</volume>:<fpage>e1003238</fpage>.<pub-id pub-id-type="pmid">23555251</pub-id></mixed-citation></ref><ref id="iub2356-bib-0083"><label>83</label><mixed-citation publication-type="journal" id="iub2356-cit-0083">
<string-name>
<surname>Avadhanula</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Rodriguez</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>DeVincenzo</surname>
<given-names>JP</given-names>
</string-name>, et al. <article-title>Respiratory viruses augment the adhesion of bacterial pathogens to respiratory epithelium in a viral species&#x02010;and cell type&#x02010;dependent manner</article-title>. <source xml:lang="en">J Virol</source>. <year>2006</year>;<volume>80</volume>:<fpage>1629</fpage>&#x02013;<lpage>1636</lpage>.<pub-id pub-id-type="pmid">16439519</pub-id></mixed-citation></ref><ref id="iub2356-bib-0084"><label>84</label><mixed-citation publication-type="journal" id="iub2356-cit-0084">
<string-name>
<surname>Novotny</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Bakaletz</surname>
<given-names>LO</given-names>
</string-name>. <article-title>Intercellular adhesion molecule 1 serves as a primary cognate receptor for the type IV pilus of nontypeable <italic>Haemophilus influenzae</italic>
</article-title>. <source xml:lang="en">Cell Microbiol</source>. <year>2016</year>;<volume>18</volume>:<fpage>1043</fpage>&#x02013;<lpage>1055</lpage>.<pub-id pub-id-type="pmid">26857242</pub-id></mixed-citation></ref><ref id="iub2356-bib-0085"><label>85</label><mixed-citation publication-type="journal" id="iub2356-cit-0085">
<string-name>
<surname>Hament</surname>
<given-names>J&#x02010;M</given-names>
</string-name>, <string-name>
<surname>Aerts</surname>
<given-names>PC</given-names>
</string-name>, <string-name>
<surname>Fleer</surname>
<given-names>A</given-names>
</string-name>, et al. <article-title>Enhanced adherence of <italic>Streptococcus pneumoniae</italic> to human epithelial cells infected with respiratory syncytial virus</article-title>. <source xml:lang="en">Pediatr Res</source>. <year>2004</year>;<volume>55</volume>:<fpage>972</fpage>&#x02013;<lpage>978</lpage>.<pub-id pub-id-type="pmid">15103015</pub-id></mixed-citation></ref><ref id="iub2356-bib-0086"><label>86</label><mixed-citation publication-type="journal" id="iub2356-cit-0086">
<string-name>
<surname>Esposito</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Zampiero</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Terranova</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Pneumococcal bacterial load colonization as a marker of mixed infection in children with alveolar community&#x02010;acquired pneumonia and respiratory syncytial virus or rhinovirus infection</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>. <year>2013</year>;<volume>32</volume>:<fpage>1199</fpage>&#x02013;<lpage>1204</lpage>.<pub-id pub-id-type="pmid">23743541</pub-id></mixed-citation></ref><ref id="iub2356-bib-0087"><label>87</label><mixed-citation publication-type="journal" id="iub2356-cit-0087">
<string-name>
<surname>Wolter</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Tempia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2014</year>;<volume>210</volume>:<fpage>1649</fpage>&#x02013;<lpage>1657</lpage>.<pub-id pub-id-type="pmid">24907383</pub-id></mixed-citation></ref><ref id="iub2356-bib-0088"><label>88</label><mixed-citation publication-type="journal" id="iub2356-cit-0088">
<string-name>
<surname>Braciale</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Sun</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>TS</given-names>
</string-name>. <article-title>Regulating the adaptive immune response to respiratory virus infection</article-title>. <source xml:lang="en">Nat Rev Immunol</source>. <year>2012</year>;<volume>12</volume>:<fpage>295</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="pmid">22402670</pub-id></mixed-citation></ref><ref id="iub2356-bib-0089"><label>89</label><mixed-citation publication-type="journal" id="iub2356-cit-0089">
<string-name>
<surname>Lijek</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Weiser</surname>
<given-names>JN</given-names>
</string-name>. <article-title>Co&#x02010;infection subverts mucosal immunity in the upper respiratory tract</article-title>. <source xml:lang="en">Curr Opin Immunol</source>. <year>2012</year>;<volume>24</volume>:<fpage>417</fpage>&#x02013;<lpage>423</lpage>.<pub-id pub-id-type="pmid">22658762</pub-id></mixed-citation></ref><ref id="iub2356-bib-0090"><label>90</label><mixed-citation publication-type="journal" id="iub2356-cit-0090">
<string-name>
<surname>Ghoneim</surname>
<given-names>HE</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>McCullers</surname>
<given-names>JA</given-names>
</string-name>. <article-title>Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections</article-title>. <source xml:lang="en">J Immunol</source>. <year>2013</year>;<volume>191</volume>:<fpage>1250</fpage>&#x02013;<lpage>1259</lpage>.<pub-id pub-id-type="pmid">23804714</pub-id></mixed-citation></ref><ref id="iub2356-bib-0091"><label>91</label><mixed-citation publication-type="journal" id="iub2356-cit-0091">
<string-name>
<surname>Sun</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Metzger</surname>
<given-names>DW</given-names>
</string-name>. <article-title>Influenza infection suppresses NADPH oxidase&#x02013;dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin&#x02010;resistant <italic>Staphylococcus aureus</italic> infection</article-title>. <source xml:lang="en">J Immunol</source>. <year>2014</year>;<volume>192</volume>:<fpage>3301</fpage>&#x02013;<lpage>3307</lpage>.<pub-id pub-id-type="pmid">24563256</pub-id></mixed-citation></ref><ref id="iub2356-bib-0092"><label>92</label><mixed-citation publication-type="journal" id="iub2356-cit-0092">
<string-name>
<surname>Davidson</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Maini</surname>
<given-names>MK</given-names>
</string-name>, <string-name>
<surname>Wack</surname>
<given-names>A</given-names>
</string-name>. <article-title>Disease&#x02010;promoting effects of type I interferons in viral, bacterial, and coinfections</article-title>. <source xml:lang="en">J Interferon Cytokine Res</source>. <year>2015</year>;<volume>35</volume>:<fpage>252</fpage>&#x02013;<lpage>264</lpage>.<pub-id pub-id-type="pmid">25714109</pub-id></mixed-citation></ref><ref id="iub2356-bib-0093"><label>93</label><mixed-citation publication-type="journal" id="iub2356-cit-0093">
<string-name>
<surname>Mehta</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Petes</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Gee</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Basta</surname>
<given-names>S</given-names>
</string-name>. <article-title>The role of virus infection in deregulating the cytokine response to secondary bacterial infection</article-title>. <source xml:lang="en">J Interferon Cytokine Res</source>. <year>2015</year>;<volume>35</volume>:<fpage>925</fpage>&#x02013;<lpage>934</lpage>.<pub-id pub-id-type="pmid">26308503</pub-id></mixed-citation></ref><ref id="iub2356-bib-0094"><label>94</label><mixed-citation publication-type="journal" id="iub2356-cit-0094">
<string-name>
<surname>Robinson</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Kolls</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Alcorn</surname>
<given-names>JF</given-names>
</string-name>. <article-title>The immunology of influenza virus&#x02010;associated bacterial pneumonia</article-title>. <source xml:lang="en">Curr Opin Immunol</source>. <year>2015</year>;<volume>34</volume>:<fpage>59</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">25723597</pub-id></mixed-citation></ref><ref id="iub2356-bib-0095"><label>95</label><mixed-citation publication-type="journal" id="iub2356-cit-0095">
<string-name>
<surname>McGillivary</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Mason</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Jurcisek</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Peeples</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>Bakaletz</surname>
<given-names>LO</given-names>
</string-name>. <article-title>Respiratory syncytial virus&#x02010;induced dysregulation of expression of a mucosal &#x003b2;&#x02010;defensin augments colonization of the upper airway by non&#x02010;typeable <italic>Haemophilus influenzae</italic>
</article-title>. <source xml:lang="en">Cell Microbiol</source>. <year>2009</year>;<volume>11</volume>:<fpage>1399</fpage>&#x02013;<lpage>1408</lpage>.<pub-id pub-id-type="pmid">19500108</pub-id></mixed-citation></ref><ref id="iub2356-bib-0096"><label>96</label><mixed-citation publication-type="journal" id="iub2356-cit-0096">
<string-name>
<surname>Sanford</surname>
<given-names>BA</given-names>
</string-name>, <string-name>
<surname>Shelokov</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ramsay</surname>
<given-names>MA</given-names>
</string-name>. <article-title>Bacterial adherence to virus&#x02010;infected cells: A cell culture model of bacterial superinfection</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>1978</year>;<volume>137</volume>:<fpage>176</fpage>&#x02013;<lpage>181</lpage>.<pub-id pub-id-type="pmid">627737</pub-id></mixed-citation></ref><ref id="iub2356-bib-0097"><label>97</label><mixed-citation publication-type="journal" id="iub2356-cit-0097">
<string-name>
<surname>Ramphal</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Small</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Shands</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Fischlschweiger</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Small</surname>
<given-names>P</given-names>
</string-name>. <article-title>Adherence of <italic>Pseudomonas aeruginosa</italic> to tracheal cells injured by influenza infection or by endotracheal intubation</article-title>. <source xml:lang="en">Infect Immun</source>. <year>1980</year>;<volume>27</volume>:<fpage>614</fpage>&#x02013;<lpage>619</lpage>.<pub-id pub-id-type="pmid">6769805</pub-id></mixed-citation></ref><ref id="iub2356-bib-0098"><label>98</label><mixed-citation publication-type="journal" id="iub2356-cit-0098">
<string-name>
<surname>Galina</surname>
<given-names>L</given-names>
</string-name>. <article-title>Possible mechanisms of viral&#x02010;bacterial interaction in swine</article-title>. <source xml:lang="en">Swine Health Prod</source>. <year>1995</year>;<volume>3</volume>:<fpage>9</fpage>&#x02013;<lpage>14</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0099"><label>99</label><mixed-citation publication-type="book" id="iub2356-cit-0099">
<string-name>
<surname>Babiuk</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Lawman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ohmann</surname>
<given-names>HB</given-names>
</string-name>. <chapter-title>Viral&#x02010;bacterial synergistic interaction in respiratory disease</chapter-title>
<source xml:lang="en">Advances in virus research</source>. Volume <volume>35</volume>
<publisher-name>Elsevier</publisher-name>, <year>1988</year>; p. <fpage>219</fpage>&#x02013;<lpage>249</lpage>.<pub-id pub-id-type="pmid">3148270</pub-id></mixed-citation></ref><ref id="iub2356-bib-0100"><label>100</label><mixed-citation publication-type="journal" id="iub2356-cit-0100">
<string-name>
<surname>Iglesias</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Pijoan</surname>
<given-names>C</given-names>
</string-name>. <article-title>Effect of swine fever live vaccine on the mucociliary apparatus of swine, and its interaction with <italic>Pasteurella multocida</italic>
</article-title>. <source xml:lang="en">Rev Lat Microbiol</source>. <year>1980</year>;<volume>22</volume>:<fpage>52</fpage>.</mixed-citation></ref><ref id="iub2356-bib-0101"><label>101</label><mixed-citation publication-type="journal" id="iub2356-cit-0101">
<string-name>
<surname>Kleinerman</surname>
<given-names>ES</given-names>
</string-name>, <string-name>
<surname>Daniels</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Polisson</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Snyderman</surname>
<given-names>R</given-names>
</string-name>. <article-title>Effect of virus infection on the inflammatory response. Depression of macrophage accumulation in influenza&#x02010;infected mice</article-title>. <source xml:lang="en">Am J Pathol</source>. <year>1976</year>;<volume>85</volume>:<fpage>373</fpage>.<pub-id pub-id-type="pmid">11695</pub-id></mixed-citation></ref><ref id="iub2356-bib-0102"><label>102</label><mixed-citation publication-type="journal" id="iub2356-cit-0102">
<string-name>
<surname>Warr</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Jakab</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hearst</surname>
<given-names>J</given-names>
</string-name>. <article-title>Alterations in lung macrophage immune receptor (s) activity associated with viral pneumonia</article-title>. <source xml:lang="en">RES J Reticuloendothel Soc</source>. <year>1979</year>;<volume>26</volume>:<fpage>357</fpage>&#x02013;<lpage>366</lpage>.<pub-id pub-id-type="pmid">229220</pub-id></mixed-citation></ref><ref id="iub2356-bib-0103"><label>103</label><mixed-citation publication-type="journal" id="iub2356-cit-0103">
<string-name>
<surname>Warr</surname>
<given-names>GA</given-names>
</string-name>, <string-name>
<surname>Jakab</surname>
<given-names>GJ</given-names>
</string-name>. <article-title>Alterations in lung macrophage antimicrobial activity associated with viral pneumonia</article-title>. <source xml:lang="en">Infect Immun</source>. <year>1979</year>;<volume>26</volume>:<fpage>492</fpage>&#x02013;<lpage>497</lpage>.<pub-id pub-id-type="pmid">232689</pub-id></mixed-citation></ref><ref id="iub2356-bib-0104"><label>104</label><mixed-citation publication-type="journal" id="iub2356-cit-0104">
<string-name>
<surname>Taneja</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sharma</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hallett</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Findlay</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Morris</surname>
<given-names>M</given-names>
</string-name>. <article-title>Immature circulating neutrophils in sepsis have impaired phagocytosis and calcium signaling</article-title>. <source xml:lang="en">Shock (Augusta, GA)</source>. <year>2008</year>;<volume>30</volume>:<fpage>618</fpage>&#x02013;<lpage>622</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0105"><label>105</label><mixed-citation publication-type="journal" id="iub2356-cit-0105">
<string-name>
<surname>Grudzinska</surname>
<given-names>FS</given-names>
</string-name>, <string-name>
<surname>Brodlie</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Scholefield</surname>
<given-names>BR</given-names>
</string-name>, et al. <article-title>Neutrophils in community&#x02010;acquired pneumonia: Parallels in dysfunction at the extremes of age</article-title>. <source xml:lang="en">Thorax</source>. <year>2020</year>;<volume>75</volume>:<fpage>164</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">31732687</pub-id></mixed-citation></ref><ref id="iub2356-bib-0106"><label>106</label><mixed-citation publication-type="journal" id="iub2356-cit-0106">
<string-name>
<surname>Ciencewicki</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Gowdy</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Krantz</surname>
<given-names>QT</given-names>
</string-name>, et al. <article-title>Diesel exhaust enhanced susceptibility to influenza infection is associated with decreased surfactant protein expression</article-title>. <source xml:lang="en">Inhal Toxicol</source>. <year>2007</year>;<volume>19</volume>:<fpage>1121</fpage>&#x02013;<lpage>1133</lpage>.<pub-id pub-id-type="pmid">17987464</pub-id></mixed-citation></ref><ref id="iub2356-bib-0107"><label>107</label><mixed-citation publication-type="journal" id="iub2356-cit-0107">
<string-name>
<surname>Kongchanagul</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Suptawiwat</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Boonarkart</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Decreased expression of surfactant protein D mRNA in human lungs in fatal cases of H5N1 avian influenza</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2011</year>;<volume>83</volume>:<fpage>1410</fpage>&#x02013;<lpage>1417</lpage>.<pub-id pub-id-type="pmid">21678446</pub-id></mixed-citation></ref><ref id="iub2356-bib-0108"><label>108</label><mixed-citation publication-type="journal" id="iub2356-cit-0108">
<string-name>
<surname>Hanada</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pirzadeh</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Carver</surname>
<given-names>KY</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>JC</given-names>
</string-name>. <article-title>Respiratory viral infection&#x02010;induced microbiome alterations and secondary bacterial pneumonia</article-title>. <source xml:lang="en">Front Immunol</source>. <year>2018</year>;<volume>9</volume>:<fpage>2640</fpage>.<pub-id pub-id-type="pmid">30505304</pub-id></mixed-citation></ref><ref id="iub2356-bib-0109"><label>109</label><mixed-citation publication-type="journal" id="iub2356-cit-0109">
<string-name>
<surname>Qin</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Role of autophagy and apoptosis in the Postinfluenza bacterial pneumonia</article-title>. <source xml:lang="en">Biomed Res Int</source>. <year>2016</year>;<volume>2016</volume>:<elocation-id>3801026</elocation-id>.<pub-id pub-id-type="pmid">27376082</pub-id></mixed-citation></ref><ref id="iub2356-bib-0110"><label>110</label><mixed-citation publication-type="journal" id="iub2356-cit-0110">
<string-name>
<surname>Sadler</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Williams</surname>
<given-names>BR</given-names>
</string-name>. <article-title>Interferon&#x02010;inducible antiviral effectors</article-title>. <source xml:lang="en">Nat Rev Immunol</source>. <year>2008</year>;<volume>8</volume>:<fpage>559</fpage>&#x02013;<lpage>568</lpage>.<pub-id pub-id-type="pmid">18575461</pub-id></mixed-citation></ref><ref id="iub2356-bib-0111"><label>111</label><mixed-citation publication-type="journal" id="iub2356-cit-0111">
<string-name>
<surname>Shahangian</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Chow</surname>
<given-names>EK</given-names>
</string-name>, <string-name>
<surname>Tian</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source xml:lang="en">J Clin Invest</source>. <year>2009</year>;<volume>119</volume>:<fpage>1910</fpage>&#x02013;<lpage>1920</lpage>.<pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="iub2356-bib-0112"><label>112</label><mixed-citation publication-type="journal" id="iub2356-cit-0112">
<string-name>
<surname>Robinson</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>McHugh</surname>
<given-names>KJ</given-names>
</string-name>, <string-name>
<surname>Mandalapu</surname>
<given-names>S</given-names>
</string-name>, et al. <article-title>Influenza a virus exacerbates <italic>Staphylococcus aureus</italic> pneumonia in mice by attenuating antimicrobial peptide production</article-title>. <source xml:lang="en">J Infect Dis</source>. <year>2014</year>;<volume>209</volume>:<fpage>865</fpage>&#x02013;<lpage>875</lpage>.<pub-id pub-id-type="pmid">24072844</pub-id></mixed-citation></ref><ref id="iub2356-bib-0113"><label>113</label><mixed-citation publication-type="journal" id="iub2356-cit-0113">
<string-name>
<surname>Lee</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>McHugh</surname>
<given-names>KJ</given-names>
</string-name>, et al. <article-title>Influenza&#x02010;induced type I interferon enhances susceptibility to gram&#x02010;negative and gram&#x02010;positive bacterial pneumonia in mice</article-title>. <source xml:lang="en">Am J Physiol Lung Cell Mol Physiol</source>. <year>2015</year>;<volume>309</volume>:<fpage>L158</fpage>&#x02013;<lpage>L167</lpage>.<pub-id pub-id-type="pmid">26001778</pub-id></mixed-citation></ref><ref id="iub2356-bib-0114"><label>114</label><mixed-citation publication-type="journal" id="iub2356-cit-0114">
<string-name>
<surname>Rynda&#x02010;Apple</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Robinson</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Alcorn</surname>
<given-names>JF</given-names>
</string-name>. <article-title>Influenza and bacterial superinfection: Illuminating the immunologic mechanisms of disease</article-title>. <source xml:lang="en">Infect Immun</source>. <year>2015</year>;<volume>83</volume>:<fpage>3764</fpage>&#x02013;<lpage>3770</lpage>.<pub-id pub-id-type="pmid">26216421</pub-id></mixed-citation></ref><ref id="iub2356-bib-0115"><label>115</label><mixed-citation publication-type="journal" id="iub2356-cit-0115">
<string-name>
<surname>Melvin</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Bomberger</surname>
<given-names>JM</given-names>
</string-name>. <article-title>Compromised defenses: Exploitation of epithelial responses during viral&#x02010;bacterial co&#x02010;infection of the respiratory tract</article-title>. <source xml:lang="en">PLoS Pathog</source>. <year>2016</year>;<volume>12</volume>:<fpage>e1005797</fpage>.<pub-id pub-id-type="pmid">27631788</pub-id></mixed-citation></ref><ref id="iub2356-bib-0116"><label>116</label><mixed-citation publication-type="journal" id="iub2356-cit-0116">
<string-name>
<surname>Siegel</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Roche</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Weiser</surname>
<given-names>JN</given-names>
</string-name>. <article-title>Influenza promotes pneumococcal growth during coinfection by providing host sialylated substrates as a nutrient source</article-title>. <source xml:lang="en">Cell Host Microbe</source>. <year>2014</year>;<volume>16</volume>:<fpage>55</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">25011108</pub-id></mixed-citation></ref><ref id="iub2356-bib-0117"><label>117</label><mixed-citation publication-type="journal" id="iub2356-cit-0117">
<string-name>
<surname>Hendricks</surname>
<given-names>MR</given-names>
</string-name>, <string-name>
<surname>Lashua</surname>
<given-names>LP</given-names>
</string-name>, <string-name>
<surname>Fischer</surname>
<given-names>DK</given-names>
</string-name>, et al. <article-title>Respiratory syncytial virus infection enhances <italic>Pseudomonas aeruginosa</italic> biofilm growth through dysregulation of nutritional immunity</article-title>. <source xml:lang="en">Proc Natl Acad Sci</source>. <year>2016</year>;<volume>113</volume>:<fpage>1642</fpage>&#x02013;<lpage>1647</lpage>.<pub-id pub-id-type="pmid">26729873</pub-id></mixed-citation></ref><ref id="iub2356-bib-0118"><label>118</label><mixed-citation publication-type="journal" id="iub2356-cit-0118">
<string-name>
<surname>Hennigar</surname>
<given-names>SR</given-names>
</string-name>, <string-name>
<surname>McClung</surname>
<given-names>JP</given-names>
</string-name>. <article-title>Nutritional immunity: Starving pathogens of trace minerals</article-title>. <source xml:lang="en">Am J Lifestyle Med</source>. <year>2016</year>;<volume>10</volume>:<fpage>170</fpage>&#x02013;<lpage>173</lpage>.<pub-id pub-id-type="pmid">30202269</pub-id></mixed-citation></ref><ref id="iub2356-bib-0119"><label>119</label><mixed-citation publication-type="journal" id="iub2356-cit-0119">
<string-name>
<surname>Pawlowski</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jansson</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sk&#x000f6;ld</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rottenberg</surname>
<given-names>ME</given-names>
</string-name>, <string-name>
<surname>K&#x000e4;llenius</surname>
<given-names>G</given-names>
</string-name>. <article-title>Tuberculosis and HIV co&#x02010;infection</article-title>. <source xml:lang="en">PLoS Pathog</source>. <year>2012</year>;<volume>8</volume>:<fpage>e1002464</fpage>.<pub-id pub-id-type="pmid">22363214</pub-id></mixed-citation></ref><ref id="iub2356-bib-0120"><label>120</label><mixed-citation publication-type="journal" id="iub2356-cit-0120">
<string-name>
<surname>Murray</surname>
<given-names>JF</given-names>
</string-name>. <article-title>Epidemiology of human immunodeficiency virus&#x02013;associated pulmonary disease</article-title>. <source xml:lang="en">Clin Chest Med</source>. <year>2013</year>;<volume>34</volume>:<fpage>165</fpage>&#x02013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">23702168</pub-id></mixed-citation></ref><ref id="iub2356-bib-0121"><label>121</label><mixed-citation publication-type="journal" id="iub2356-cit-0121">
<string-name>
<surname>Vittor</surname>
<given-names>AY</given-names>
</string-name>, <string-name>
<surname>Garland</surname>
<given-names>JM</given-names>
</string-name>, <string-name>
<surname>Gilman</surname>
<given-names>RH</given-names>
</string-name>. <article-title>Molecular diagnosis of TB in the HIV positive population</article-title>. <source xml:lang="en">Ann Glob Health</source>. <year>2014</year>;<volume>80</volume>:<fpage>476</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">25960097</pub-id></mixed-citation></ref><ref id="iub2356-bib-0122"><label>122</label><mixed-citation publication-type="journal" id="iub2356-cit-0122">
<string-name>
<surname>Tashiro</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ciborowski</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Klenk</surname>
<given-names>H&#x02010;D</given-names>
</string-name>, <string-name>
<surname>Pulverer</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Rott</surname>
<given-names>R</given-names>
</string-name>. <article-title>Role of Staphylococcus protease in the development of influenza pneumonia</article-title>. <source xml:lang="en">Nature</source>. <year>1987</year>;<volume>325</volume>:<fpage>536</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">3543690</pub-id></mixed-citation></ref><ref id="iub2356-bib-0123"><label>123</label><mixed-citation publication-type="journal" id="iub2356-cit-0123">
<string-name>
<surname>Conenello</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Zamarin</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Perrone</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Tumpey</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Palese</surname>
<given-names>P</given-names>
</string-name>. <article-title>A single mutation in the PB1&#x02010;F2 of H5N1 (HK/97) and 1918 influenza a viruses contributes to increased virulence</article-title>. <source xml:lang="en">PLoS Pathog</source>. <year>2007</year>;<volume>3</volume>:<fpage>1414</fpage>&#x02013;<lpage>1421</lpage>.<pub-id pub-id-type="pmid">17922571</pub-id></mixed-citation></ref><ref id="iub2356-bib-0124"><label>124</label><mixed-citation publication-type="journal" id="iub2356-cit-0124">
<string-name>
<surname>Chattoraj</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Ganesan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells</article-title>. <source xml:lang="en">Thorax</source>. <year>2011</year>;<volume>66</volume>:<fpage>333</fpage>&#x02013;<lpage>339</lpage>.<pub-id pub-id-type="pmid">21289024</pub-id></mixed-citation></ref><ref id="iub2356-bib-0125"><label>125</label><mixed-citation publication-type="journal" id="iub2356-cit-0125">
<string-name>
<surname>Pettigrew</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Marks</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Kong</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Gent</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Roche&#x02010;Hakansson</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hakansson</surname>
<given-names>AP</given-names>
</string-name>. <article-title>Dynamic changes in the <italic>Streptococcus pneumoniae</italic> transcriptome during transition from biofilm formation to invasive disease upon influenza a virus infection</article-title>. <source xml:lang="en">Infect Immun</source>. <year>2014</year>;<volume>82</volume>:<fpage>4607</fpage>&#x02013;<lpage>4619</lpage>.<pub-id pub-id-type="pmid">25135685</pub-id></mixed-citation></ref><ref id="iub2356-bib-0126"><label>126</label><mixed-citation publication-type="journal" id="iub2356-cit-0126">
<string-name>
<surname>Chao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Marks</surname>
<given-names>LR</given-names>
</string-name>, <string-name>
<surname>Pettigrew</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Hakansson</surname>
<given-names>AP</given-names>
</string-name>. <article-title>
<italic>Streptococcus pneumoniae</italic> biofilm formation and dispersion during colonization and disease</article-title>. <source xml:lang="en">Front Cell Infect Microbiol</source>. <year>2015</year>;<volume>4</volume>:<fpage>194</fpage>.<pub-id pub-id-type="pmid">25629011</pub-id></mixed-citation></ref><ref id="iub2356-bib-0127"><label>127</label><mixed-citation publication-type="journal" id="iub2356-cit-0127">
<string-name>
<surname>di Mauro</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Cristina</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Concetta</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Francesco</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Annalisa</surname>
<given-names>C</given-names>
</string-name>. <article-title>SARS&#x02010;Cov&#x02010;2 infection: Response of human immune system and possible implications for the rapid test and treatment</article-title>. <source xml:lang="en">Int Immunopharmacol</source>. <year>2020</year>;<volume>84</volume>:<fpage>106519</fpage>&#x02013;<lpage>106519</lpage>.<pub-id pub-id-type="pmid">32311668</pub-id></mixed-citation></ref><ref id="iub2356-bib-0128"><label>128</label><mixed-citation publication-type="journal" id="iub2356-cit-0128">
<string-name>
<surname>Nikolich&#x02010;Zugich</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Knox</surname>
<given-names>KS</given-names>
</string-name>, <string-name>
<surname>Rios</surname>
<given-names>CT</given-names>
</string-name>, et al. <article-title>SARS&#x02010;CoV&#x02010;2 and COVID&#x02010;19 in older adults: What we may expect regarding pathogenesis, immune responses, and outcomes</article-title>. <source xml:lang="en">GeroScience</source>. <year>2020</year>;<volume>42</volume>(<issue>2</issue>):<fpage>505</fpage>&#x02013;<lpage>514</lpage>.<pub-id pub-id-type="pmid">32274617</pub-id></mixed-citation></ref><ref id="iub2356-bib-0129"><label>129</label><mixed-citation publication-type="book" id="iub2356-cit-0129">
<string-name>
<surname>Li</surname>
<given-names>CK&#x02010;f</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>X</given-names>
</string-name>. <chapter-title>Host immune responses to SARS coronavirus in humans</chapter-title>
<source xml:lang="en">Molecular biology of the SARS&#x02010;coronavirus</source>, <year>2009</year>; p. <fpage>259</fpage>&#x02013;<lpage>278</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0130"><label>130</label><mixed-citation publication-type="miscellaneous" id="iub2356-cit-0130">
<string-name>
<surname>Frieman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Baric</surname>
<given-names>R.</given-names>
</string-name>
<article-title>Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation. Microbiology and molecular biology reviews: MMBR 72, 672&#x02013;685, Table of Contents</article-title>, <year>2008</year>.</mixed-citation></ref><ref id="iub2356-bib-0131"><label>131</label><mixed-citation publication-type="journal" id="iub2356-cit-0131">
<string-name>
<surname>Cinatl</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Morgenstern</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Bauer</surname>
<given-names>G</given-names>
</string-name>, et al. <article-title>Treatment of SARS with human interferons</article-title>. <source xml:lang="en">Lancet (London, England)</source>. <year>2003</year>;<volume>362</volume>:<fpage>293</fpage>&#x02013;<lpage>294</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0132"><label>132</label><mixed-citation publication-type="journal" id="iub2356-cit-0132">
<string-name>
<surname>Spiegel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Pichlmair</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Martinez&#x02010;Sobrido</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two&#x02010;step model for activation of interferon regulatory factor 3</article-title>. <source xml:lang="en">J Virol</source>. <year>2005</year>;<volume>79</volume>:<fpage>2079</fpage>&#x02013;<lpage>2086</lpage>.<pub-id pub-id-type="pmid">15681410</pub-id></mixed-citation></ref><ref id="iub2356-bib-0133"><label>133</label><mixed-citation publication-type="journal" id="iub2356-cit-0133">
<string-name>
<surname>Haagmans</surname>
<given-names>BL</given-names>
</string-name>, <string-name>
<surname>Kuiken</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Martina</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Fouchier</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Rimmelzwaan</surname>
<given-names>GF</given-names>
</string-name>, et al. <article-title>Pegylated interferon&#x02010;alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques</article-title>. <source xml:lang="en">Nat Med</source>. <year>2004</year>;<volume>10</volume>:<fpage>290</fpage>&#x02013;<lpage>293</lpage>.<pub-id pub-id-type="pmid">14981511</pub-id></mixed-citation></ref><ref id="iub2356-bib-0134"><label>134</label><mixed-citation publication-type="journal" id="iub2356-cit-0134">
<string-name>
<surname>Freundt</surname>
<given-names>EC</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Lenardo</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>XN</given-names>
</string-name>. <article-title>Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein</article-title>. <source xml:lang="en">J Virol</source>. <year>2009</year>;<volume>83</volume>:<fpage>6631</fpage>&#x02013;<lpage>6640</lpage>.<pub-id pub-id-type="pmid">19403678</pub-id></mixed-citation></ref><ref id="iub2356-bib-0135"><label>135</label><mixed-citation publication-type="journal" id="iub2356-cit-0135">
<string-name>
<surname>Narayanan</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Lokugamage</surname>
<given-names>K</given-names>
</string-name>, et al. <article-title>Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells</article-title>. <source xml:lang="en">J Virol</source>. <year>2008</year>;<volume>82</volume>:<fpage>4471</fpage>&#x02013;<lpage>4479</lpage>.<pub-id pub-id-type="pmid">18305050</pub-id></mixed-citation></ref><ref id="iub2356-bib-0136"><label>136</label><mixed-citation publication-type="journal" id="iub2356-cit-0136">
<string-name>
<surname>Devaraj</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>Z</given-names>
</string-name>, et al. <article-title>Regulation of IRF&#x02010;3&#x02010;dependent innate immunity by the papain&#x02010;like protease domain of the severe acute respiratory syndrome coronavirus</article-title>. <source xml:lang="en">J Biol Chem</source>. <year>2007</year>;<volume>282</volume>:<fpage>32208</fpage>&#x02013;<lpage>32221</lpage>.<pub-id pub-id-type="pmid">17761676</pub-id></mixed-citation></ref><ref id="iub2356-bib-0137"><label>137</label><mixed-citation publication-type="journal" id="iub2356-cit-0137">
<string-name>
<surname>Krahling</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Stein</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Spiegel</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Weber</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Muhlberger</surname>
<given-names>E</given-names>
</string-name>. <article-title>Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity</article-title>. <source xml:lang="en">J Virol</source>. <year>2009</year>;<volume>83</volume>:<fpage>2298</fpage>&#x02013;<lpage>2309</lpage>.<pub-id pub-id-type="pmid">19109397</pub-id></mixed-citation></ref><ref id="iub2356-bib-0138"><label>138</label><mixed-citation publication-type="journal" id="iub2356-cit-0138">
<string-name>
<surname>Bezerra</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Britto</surname>
<given-names>MC</given-names>
</string-name>, <string-name>
<surname>Correia</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Duarte</surname>
<given-names>MdCM</given-names>
</string-name>, <string-name>
<surname>Fonceca</surname>
<given-names>AM</given-names>
</string-name>, et al. <article-title>Viral and atypical bacterial detection in acute respiratory infection in children under five years</article-title>. <source xml:lang="en">PloS One</source>. <year>2011</year>;<volume>6</volume>:<elocation-id>e18928</elocation-id>.<pub-id pub-id-type="pmid">21533115</pub-id></mixed-citation></ref><ref id="iub2356-bib-0139"><label>139</label><mixed-citation publication-type="journal" id="iub2356-cit-0139">
<string-name>
<surname>Binks</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Cheng</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Smith&#x02010;Vaughan</surname>
<given-names>H</given-names>
</string-name>, et al. <article-title>Viral&#x02010;bacterial co&#x02010;infection in Australian indigenous children with acute otitis media</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2011</year>;<volume>11</volume>:<elocation-id>161</elocation-id>.<pub-id pub-id-type="pmid">21649905</pub-id></mixed-citation></ref><ref id="iub2356-bib-0140"><label>140</label><mixed-citation publication-type="journal" id="iub2356-cit-0140">
<string-name>
<surname>Johansson</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kalin</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hedlund</surname>
<given-names>J</given-names>
</string-name>. <article-title>Clinical impact of combined viral and bacterial infection in patients with community&#x02010;acquired pneumonia</article-title>. <source xml:lang="en">Scand J Infect Dis</source>. <year>2011</year>;<volume>43</volume>:<fpage>609</fpage>&#x02013;<lpage>615</lpage>.<pub-id pub-id-type="pmid">21466255</pub-id></mixed-citation></ref><ref id="iub2356-bib-0141"><label>141</label><mixed-citation publication-type="journal" id="iub2356-cit-0141">
<string-name>
<surname>Edrada</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Lopez</surname>
<given-names>EB</given-names>
</string-name>, <string-name>
<surname>Villarama</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Villarama</surname>
<given-names>EPS</given-names>
</string-name>, <string-name>
<surname>Dagoc</surname>
<given-names>BF</given-names>
</string-name>, et al. <article-title>First COVID&#x02010;19 infections in the Philippines: A case report</article-title>. <source xml:lang="en">Trop Med Health</source>. <year>2020</year>;<volume>48</volume>:<fpage>1</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">31920458</pub-id></mixed-citation></ref><ref id="iub2356-bib-0142"><label>142</label><mixed-citation publication-type="journal" id="iub2356-cit-0142">
<string-name>
<surname>Kaiser</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Regamey</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Roiha</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Deffernez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Frey</surname>
<given-names>U</given-names>
</string-name>. <article-title>Human coronavirus NL63 associated with lower respiratory tract symptoms in early life</article-title>. <source xml:lang="en">Pediatr Infect Dis J</source>. <year>2005</year>;<volume>24</volume>:<fpage>1015</fpage>&#x02013;<lpage>1017</lpage>.<pub-id pub-id-type="pmid">16282944</pub-id></mixed-citation></ref><ref id="iub2356-bib-0143"><label>143</label><mixed-citation publication-type="journal" id="iub2356-cit-0143">
<string-name>
<surname>Golda</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Malek</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Dudek</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Infection with human coronavirus NL63 enhances streptococcal adherence to epithelial cells</article-title>. <source xml:lang="en">J Gen Virol</source>. <year>2011</year>;<volume>92</volume>:<fpage>1358</fpage>&#x02013;<lpage>1368</lpage>.<pub-id pub-id-type="pmid">21325482</pub-id></mixed-citation></ref><ref id="iub2356-bib-0144"><label>144</label><mixed-citation publication-type="journal" id="iub2356-cit-0144">
<string-name>
<surname>Dijkman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Jebbink</surname>
<given-names>MF</given-names>
</string-name>, <string-name>
<surname>El Idrissi</surname>
<given-names>NB</given-names>
</string-name>, et al. <article-title>Human coronavirus NL63 and 229E seroconversion in children</article-title>. <source xml:lang="en">J Clin Microbiol</source>. <year>2008</year>;<volume>46</volume>:<fpage>2368</fpage>&#x02013;<lpage>2373</lpage>.<pub-id pub-id-type="pmid">18495857</pub-id></mixed-citation></ref><ref id="iub2356-bib-0145"><label>145</label><mixed-citation publication-type="journal" id="iub2356-cit-0145">
<string-name>
<surname>Wang</surname>
<given-names>J&#x02010;b</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>H&#x02010;z</given-names>
</string-name>, <string-name>
<surname>Huang</surname>
<given-names>X&#x02010;z</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>L</given-names>
</string-name>. <article-title>Organism distribution and drug resistance in 7 cases of severe acute respiratory syndrome death patients with secondary bacteria infection</article-title>. <source xml:lang="en">Chin Crit Care Med</source>. <year>2003</year>;<volume>15</volume>:<fpage>523</fpage>&#x02013;<lpage>525</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0146"><label>146</label><mixed-citation publication-type="journal" id="iub2356-cit-0146">
<string-name>
<surname>Chen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Zhou</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Dong</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study</article-title>. <source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>507</fpage>&#x02013;<lpage>513</lpage>.<pub-id pub-id-type="pmid">32007143</pub-id></mixed-citation></ref><ref id="iub2356-bib-0147"><label>147</label><mixed-citation publication-type="journal" id="iub2356-cit-0147">
<string-name>
<surname>Huang</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>X</given-names>
</string-name>, et al. <article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>497</fpage>&#x02013;<lpage>506</lpage>.<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="iub2356-bib-0148"><label>148</label><mixed-citation publication-type="journal" id="iub2356-cit-0148">
<string-name>
<surname>Zhang</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Hu</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Luo</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Clinical features and outcomes of 221 patients with COVID&#x02010;19 in Wuhan, China</article-title>. <source xml:lang="en">J Clin Virol</source>. <year>2020</year>;<volume>127</volume>:<fpage>104364</fpage>.<pub-id pub-id-type="pmid">32311650</pub-id></mixed-citation></ref><ref id="iub2356-bib-0149"><label>149</label><mixed-citation publication-type="journal" id="iub2356-cit-0149">
<string-name>
<surname>Blasco</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Buesa</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Colomina</surname>
<given-names>J</given-names>
</string-name>, et al. <article-title>Co&#x02010;detection of respiratory pathogens in patients hospitalized with coronavirus viral disease&#x02010;2019 pneumonia</article-title>. <source xml:lang="en">J Med Virol</source>. <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0150"><label>150</label><mixed-citation publication-type="journal" id="iub2356-cit-0150">
<string-name>
<surname>Claire</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>R&#x000e9;mi Le</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Claire</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>Panton&#x02010;valentine Leukocidin&#x02013;secreting <italic>Staphylococcus aureus</italic> pneumonia complicating COVID&#x02010;19</article-title>. <source xml:lang="en">Emerg Infect Dis J</source>. <year>2020</year>;<volume>26</volume>.</mixed-citation></ref><ref id="iub2356-bib-0151"><label>151</label><mixed-citation publication-type="journal" id="iub2356-cit-0151">
<string-name>
<surname>Bordi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Nicastri</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Scorzolini</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Differential diagnosis of illness in patients under investigation for the novel coronavirus (SARS&#x02010;CoV&#x02010;2), Italy, February 2020</article-title>. <source xml:lang="en">Eurosurveillance</source>. <year>2020</year>;<volume>25</volume>:<fpage>2000170</fpage>.</mixed-citation></ref><ref id="iub2356-bib-0152"><label>152</label><mixed-citation publication-type="journal" id="iub2356-cit-0152">
<string-name>
<surname>Duployez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Le Guern</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Tinez</surname>
<given-names>C</given-names>
</string-name>, et al. <article-title>Panton&#x02010;valentine Leukocidin&#x02010;secreting <italic>Staphylococcus aureus</italic> pneumonia complicating COVID&#x02010;19</article-title>. <source xml:lang="en">Emerg Infect Dis</source>. <year>2020</year>;<volume>26</volume>.</mixed-citation></ref><ref id="iub2356-bib-0153"><label>153</label><mixed-citation publication-type="journal" id="iub2356-cit-0153">
<string-name>
<surname>Fan</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Lim</surname>
<given-names>KGE</given-names>
</string-name>, <string-name>
<surname>Chong</surname>
<given-names>VCL</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>SSW</given-names>
</string-name>, <string-name>
<surname>Ong</surname>
<given-names>KH</given-names>
</string-name>, <string-name>
<surname>Kuperan</surname>
<given-names>P</given-names>
</string-name>. <article-title>COVID&#x02010;19 and <italic>Mycoplasma pneumoniae</italic> coinfection</article-title>. <source xml:lang="en">Am J Hematol</source>. <year>2020</year>;<volume>95</volume>:<fpage>723</fpage>&#x02013;<lpage>724</lpage>.<pub-id pub-id-type="pmid">32173883</pub-id></mixed-citation></ref><ref id="iub2356-bib-0154"><label>154</label><mixed-citation publication-type="journal" id="iub2356-cit-0154">
<string-name>
<surname>Yu</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Kang</surname>
<given-names>Q</given-names>
</string-name>, et al. <article-title>Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID&#x02010;19 in Wuhan, China: A retrospective, single&#x02010;Centre, descriptive study</article-title>. <source xml:lang="en">Lancet Infect Dis</source>. <year>2020</year>;<volume>20</volume>:<fpage>559</fpage>&#x02013;<lpage>564</lpage>.<pub-id pub-id-type="pmid">32220284</pub-id></mixed-citation></ref><ref id="iub2356-bib-0155"><label>155</label><mixed-citation publication-type="journal" id="iub2356-cit-0155">
<string-name>
<surname>Wang</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Yang</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>Q</given-names>
</string-name>, <string-name>
<surname>Wen</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>R</given-names>
</string-name>. <article-title>Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China</article-title>. <source xml:lang="en">Clin Infect Dis</source>. <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0156"><label>156</label><mixed-citation publication-type="miscellaneous" id="iub2356-cit-0156">
<string-name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</string-name>
<article-title>Metagenome of SARS&#x02010;Cov2 patients in Shenzhen with travel to Wuhan shows a wide range of species&#x02010;Lautropia, Cutibacterium, Haemophilus being most abundant&#x02010;and Campylobacter explaining diarrhea</article-title>, <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0157"><label>157</label><mixed-citation publication-type="miscellaneous" id="iub2356-cit-0157">
<string-name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</string-name>
<article-title>The 2019 Wuhan outbreak could be caused by the bacteria Prevotella, which is aided by the coronavirus, possibly to adhere to epithelial cells&#x02010;Prevotella is present in huge amounts in patients from both China and Hong Kong</article-title>, <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0158"><label>158</label><mixed-citation publication-type="miscellaneous" id="iub2356-cit-0158">
<string-name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</string-name>
<article-title>San Diego county Nanopore SARS&#x02010;Cov2 sequencing data shows metagenomic Prevotella, <italic>Haemophilus parainfluenzae</italic>, a lot of unknown species and chimeric reads</article-title>, <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0159"><label>159</label><mixed-citation publication-type="miscellaneous" id="iub2356-cit-0159">
<string-name>
<surname>Chakraborty</surname>
<given-names>S.</given-names>
</string-name>
<article-title>Metagenome of SARS&#x02010;Cov2 from a patient in Brazil shows a wide range of bacterial species&#x02010;Lautropia, Prevotella, Haemophilus&#x02010;overshadowing viral reads, which does not even add up to a full genome, explaining false negatives</article-title>, <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0160"><label>160</label><mixed-citation publication-type="journal" id="iub2356-cit-0160">
<string-name>
<surname>Tay</surname>
<given-names>MZ</given-names>
</string-name>, <string-name>
<surname>Poh</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>R&#x000e9;nia</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>MacAry</surname>
<given-names>PA</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>LF</given-names>
</string-name>. <article-title>The trinity of COVID&#x02010;19: Immunity, inflammation and intervention</article-title>. <source xml:lang="en">Nat Rev Immunol</source>. <year>2020</year>;<volume>20</volume>:<fpage>363</fpage>&#x02013;<lpage>374</lpage>.<pub-id pub-id-type="pmid">32346093</pub-id></mixed-citation></ref><ref id="iub2356-bib-0161"><label>161</label><mixed-citation publication-type="journal" id="iub2356-cit-0161">
<string-name>
<surname>MacIntyre</surname>
<given-names>CR</given-names>
</string-name>, <string-name>
<surname>Chughtai</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Barnes</surname>
<given-names>M</given-names>
</string-name>, et al. <article-title>The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N1)pdm09</article-title>. <source xml:lang="en">BMC Infect Dis</source>. <year>2018</year>;<volume>18</volume>:<fpage>637</fpage>&#x02013;<lpage>637</lpage>.<pub-id pub-id-type="pmid">30526505</pub-id></mixed-citation></ref><ref id="iub2356-bib-0162"><label>162</label><mixed-citation publication-type="journal" id="iub2356-cit-0162">
<string-name>
<surname>Cox</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Loman</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Bogaert</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>O'Grady</surname>
<given-names>J</given-names>
</string-name>. <article-title>Co&#x02010;infections: Potentially lethal and unexplored in COVID&#x02010;19</article-title>. <source xml:lang="en">Lancet Microbe</source>. <year>2020</year>;<volume>1</volume>(<issue>1</issue>):<elocation-id>e11</elocation-id>.</mixed-citation></ref><ref id="iub2356-bib-0163"><label>163</label><mixed-citation publication-type="journal" id="iub2356-cit-0163">
<string-name>
<surname>Zhou</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Du</surname>
<given-names>R</given-names>
</string-name>, et al. <article-title>Clinical course and risk factors for mortality of adult inpatients with COVID&#x02010;19 in Wuhan, China: A retrospective cohort study</article-title>. <source xml:lang="en">Lancet</source>. <year>2020</year>;<volume>395</volume>:<fpage>1054</fpage>&#x02013;<lpage>1062</lpage>.<pub-id pub-id-type="pmid">32171076</pub-id></mixed-citation></ref><ref id="iub2356-bib-0164"><label>164</label><mixed-citation publication-type="journal" id="iub2356-cit-0164">
<string-name>
<surname>Wu</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>B</given-names>
</string-name>, et al. <article-title>Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China</article-title>. <source xml:lang="en">bioRxiv</source>. <year>2020</year>.</mixed-citation></ref><ref id="iub2356-bib-0165"><label>165</label><mixed-citation publication-type="journal" id="iub2356-cit-0165">
<string-name>
<surname>Phua</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Weng</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ling</surname>
<given-names>L</given-names>
</string-name>, et al. <article-title>Intensive care management of coronavirus disease 2019 (COVID&#x02010;19): Challenges and recommendations</article-title>. <source xml:lang="en">Lancet Respir Med</source>. <year>2020</year>;<volume>8</volume>:<fpage>506</fpage>&#x02013;<lpage>517</lpage>.<pub-id pub-id-type="pmid">32272080</pub-id></mixed-citation></ref><ref id="iub2356-bib-0166"><label>166</label><mixed-citation publication-type="journal" id="iub2356-cit-0166">
<string-name>
<surname>Gautret</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Lagier</surname>
<given-names>J&#x02010;C</given-names>
</string-name>, <string-name>
<surname>Parola</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Hydroxychloroquine and azithromycin as a treatment of COVID&#x02010;19: Results of an open&#x02010;label non&#x02010;randomized clinical trial</article-title>. <source xml:lang="en">Int J Antimicrob Agents</source>. <year>2020</year>;<elocation-id>105949</elocation-id>.<pub-id pub-id-type="pmid">32205204</pub-id></mixed-citation></ref><ref id="iub2356-bib-0167"><label>167</label><mixed-citation publication-type="journal" id="iub2356-cit-0167">
<string-name>
<surname>Singh</surname>
<given-names>AK</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Shaikh</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Singh</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Misra</surname>
<given-names>A</given-names>
</string-name>. <article-title>Chloroquine and hydroxychloroquine in the treatment of COVID&#x02010;19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries</article-title>. <source xml:lang="en">Diabetes Metab Syndr</source>. <year>2020</year>;<volume>14</volume>:<fpage>241</fpage>&#x02013;<lpage>246</lpage>.<pub-id pub-id-type="pmid">32247211</pub-id></mixed-citation></ref><ref id="iub2356-bib-0168"><label>168</label><mixed-citation publication-type="journal" id="iub2356-cit-0168">
<string-name>
<surname>Serisier</surname>
<given-names>DJ</given-names>
</string-name>. <article-title>Risks of population antimicrobial resistance associated with chronic macrolide use for inflammatory airway diseases</article-title>. <source xml:lang="en">Lancet Respir Med</source>. <year>2013</year>;<volume>1</volume>:<fpage>262</fpage>&#x02013;<lpage>274</lpage>.<pub-id pub-id-type="pmid">24429132</pub-id></mixed-citation></ref><ref id="iub2356-bib-0169"><label>169</label><mixed-citation publication-type="journal" id="iub2356-cit-0169">
<string-name>
<surname>Devaux</surname>, <given-names>C</given-names>
</string-name>, <string-name>
<surname>Colson</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Raoult</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rolain</surname>
<given-names>J&#x02010;M</given-names>
</string-name>. <article-title>Teicoplanin: An alternative drug for the treatment of coronavirus COVID&#x02010;19</article-title>. <source xml:lang="en">Int J Antimicrob Agents</source>. <year>2020</year>;(<issue>4</issue>):<elocation-id>105944</elocation-id>.<pub-id pub-id-type="pmid">32179150</pub-id></mixed-citation></ref><ref id="iub2356-bib-0170"><label>170</label><mixed-citation publication-type="journal" id="iub2356-cit-0170">
<string-name>
<surname>Du</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Zhu</surname>
<given-names>P</given-names>
</string-name>, et al. <article-title>Clinical features of 85 fatal cases of COVID&#x02010;19 from Wuhan: A retrospective observational study</article-title>. <source xml:lang="en">Am J Respir Crit Care Med</source>. <year>2020</year>;<volume>201</volume>:<fpage>1372</fpage>&#x02013;<lpage>1379</lpage>.<pub-id pub-id-type="pmid">32242738</pub-id></mixed-citation></ref><ref id="iub2356-bib-0171"><label>171</label><mixed-citation publication-type="journal" id="iub2356-cit-0171">
<string-name>
<surname>Willyard</surname>
<given-names>C</given-names>
</string-name>. <article-title>The drug&#x02010;resistant bacteria that pose the greatest health threats</article-title>. <source xml:lang="en">Nat News</source>. <year>2017</year>;<volume>543</volume>:<fpage>15</fpage>.</mixed-citation></ref><ref id="iub2356-bib-0172"><label>172</label><mixed-citation publication-type="journal" id="iub2356-cit-0172">
<string-name>
<surname>Hagan</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Cortese</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Rouphael</surname>
<given-names>N</given-names>
</string-name>, et al. <article-title>Antibiotics&#x02010;driven gut microbiome perturbation alters immunity to vaccines in humans</article-title>. <source xml:lang="en">Cell</source>. <year>2019</year>;<volume>178</volume>:<fpage>1313</fpage>&#x02013;<lpage>1328.e1313</lpage>.<pub-id pub-id-type="pmid">31491384</pub-id></mixed-citation></ref><ref id="iub2356-bib-0173"><label>173</label><mixed-citation publication-type="journal" id="iub2356-cit-0173">
<string-name>
<surname>Kelly</surname>
<given-names>PN</given-names>
</string-name>. <article-title>Antibiotics blunt flu immunity</article-title>. <source xml:lang="en">Science</source>. <year>2019</year>;<volume>366</volume>:<fpage>197</fpage>&#x02013;<lpage>198</lpage>.</mixed-citation></ref><ref id="iub2356-bib-0174"><label>174</label><mixed-citation publication-type="journal" id="iub2356-cit-0174">
<string-name>
<surname>Birger</surname>
<given-names>RB</given-names>
</string-name>, <string-name>
<surname>Kouyos</surname>
<given-names>RD</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>
<given-names>T</given-names>
</string-name>, et al. <article-title>The potential impact of coinfection on antimicrobial chemotherapy and drug resistance</article-title>. <source xml:lang="en">Trends Microbiol</source>. <year>2015</year>;<volume>23</volume>:<fpage>537</fpage>&#x02013;<lpage>544</lpage>.<pub-id pub-id-type="pmid">26028590</pub-id></mixed-citation></ref><ref id="iub2356-bib-0175"><label>175</label><mixed-citation publication-type="journal" id="iub2356-cit-0175">
<string-name>
<surname>R&#x000f6;mling</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Balsalobre</surname>
<given-names>C</given-names>
</string-name>. <article-title>Biofilm infections, their resilience to therapy and innovative treatment strategies</article-title>. <source xml:lang="en">J Intern Med</source>. <year>2012</year>;<volume>272</volume>:<fpage>541</fpage>&#x02013;<lpage>561</lpage>.<pub-id pub-id-type="pmid">23025745</pub-id></mixed-citation></ref></ref-list></back></article>